2018-05-09 22:09:27,072:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 22:09:27,073:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 22:09:27,073:INFO: ======================================
2018-05-09 22:09:27,073:INFO: Loading PPI Network...
2018-05-09 22:11:01,682:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 22:11:01,683:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 22:11:01,683:INFO: ======================================
2018-05-09 22:11:01,683:INFO: Loading PPI Network...
2018-05-09 22:11:14,807:INFO: Loading Disease Associations...
2018-05-09 22:11:14,861:INFO: Running Experiment...
2018-05-09 22:13:52,042:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 22:13:52,043:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 22:13:52,043:INFO: ======================================
2018-05-09 22:13:52,043:INFO: Loading PPI Network...
2018-05-09 22:14:05,643:INFO: Loading Disease Associations...
2018-05-09 22:14:05,677:INFO: Running Experiment...
2018-05-09 22:14:05,677:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-09 22:46:15,930:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 22:46:15,930:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 22:46:15,930:INFO: ======================================
2018-05-09 22:46:15,930:INFO: Loading PPI Network...
2018-05-09 22:46:29,532:INFO: Loading Disease Associations...
2018-05-09 22:46:29,567:INFO: Running Experiment...
2018-05-09 22:46:29,567:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-09 22:47:11,286:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 22:47:11,286:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 22:47:11,286:INFO: ======================================
2018-05-09 22:47:11,287:INFO: Loading PPI Network...
2018-05-09 22:47:23,052:INFO: Loading Disease Associations...
2018-05-09 22:47:23,079:INFO: Running Experiment...
2018-05-09 22:47:23,079:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-09 22:47:38,952:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-09 23:02:33,856:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 23:02:33,856:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 23:02:33,857:INFO: ======================================
2018-05-09 23:02:33,857:INFO: Loading PPI Network...
2018-05-09 23:02:45,107:INFO: Loading Disease Associations...
2018-05-09 23:02:45,110:INFO: Running Experiment...
2018-05-09 23:02:45,110:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-09 23:03:00,973:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-09 23:27:26,363:INFO: Disease Protein Prediction in the PPI Network
2018-05-09 23:27:26,363:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-09 23:27:26,364:INFO: ======================================
2018-05-09 23:27:26,364:INFO: Loading PPI Network...
2018-05-09 23:27:38,644:INFO: Loading Disease Associations...
2018-05-09 23:27:38,649:INFO: Running Experiment...
2018-05-09 23:27:38,649:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-09 23:27:54,710:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 00:16:11,436:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 00:16:11,436:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 00:16:11,436:INFO: ======================================
2018-05-10 00:16:11,437:INFO: Loading PPI Network...
2018-05-10 00:16:22,073:INFO: Loading Disease Associations...
2018-05-10 00:16:22,078:INFO: Running Experiment...
2018-05-10 00:16:22,078:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 00:16:35,808:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 10:33:49,230:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 10:33:49,230:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 10:33:49,231:INFO: ======================================
2018-05-10 10:33:49,231:INFO: Loading PPI Network...
2018-05-10 10:33:59,544:INFO: Loading Disease Associations...
2018-05-10 10:33:59,548:INFO: Running Experiment...
2018-05-10 10:33:59,548:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 10:34:11,573:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 10:36:39,061:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 10:36:39,061:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 10:36:39,062:INFO: ======================================
2018-05-10 10:36:39,062:INFO: Loading PPI Network...
2018-05-10 10:36:49,662:INFO: Loading Disease Associations...
2018-05-10 10:36:49,666:INFO: Running Experiment...
2018-05-10 10:36:49,666:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 10:37:02,760:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 10:47:45,213:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 10:47:45,213:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 10:47:45,213:INFO: ======================================
2018-05-10 10:47:45,213:INFO: Loading PPI Network...
2018-05-10 10:47:55,319:INFO: Loading Disease Associations...
2018-05-10 10:47:55,323:INFO: Running Experiment...
2018-05-10 10:47:55,323:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 10:48:07,303:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 10:48:48,488:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 10:48:48,489:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 10:48:48,489:INFO: ======================================
2018-05-10 10:48:48,489:INFO: Loading PPI Network...
2018-05-10 10:49:00,371:INFO: Loading Disease Associations...
2018-05-10 10:49:00,378:INFO: Running Experiment...
2018-05-10 10:49:00,378:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 10:49:12,085:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 10:49:52,734:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 10:49:52,734:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 10:49:52,734:INFO: ======================================
2018-05-10 10:49:52,735:INFO: Loading PPI Network...
2018-05-10 10:50:02,263:INFO: Loading Disease Associations...
2018-05-10 10:50:02,269:INFO: Running Experiment...
2018-05-10 10:50:02,270:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 10:50:13,216:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 11:11:37,610:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 11:11:37,610:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 11:11:37,610:INFO: ======================================
2018-05-10 11:11:37,610:INFO: Loading PPI Network...
2018-05-10 11:11:47,283:INFO: Loading Disease Associations...
2018-05-10 11:11:47,287:INFO: Running Experiment...
2018-05-10 11:11:47,287:INFO: Experiment Progress: 0.0% -- 0/1
2018-05-10 11:11:58,796:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 11:52:55,562:INFO: Disease Protein Prediction in the PPI Network
2018-05-10 11:52:55,562:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-10 11:52:55,562:INFO: ======================================
2018-05-10 11:52:55,562:INFO: Loading PPI Network...
2018-05-10 11:53:05,216:INFO: Loading Disease Associations...
2018-05-10 11:53:05,235:INFO: Running Experiment...
2018-05-10 11:53:05,236:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-10 11:53:15,652:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-10 11:57:54,695:INFO: Experiment Progress: 0.2% -- 1/519
2018-05-10 12:02:39,910:INFO: Experiment Progress: 0.4% -- 2/519
2018-05-10 12:07:32,148:INFO: Experiment Progress: 0.6% -- 3/519
2018-05-10 12:12:21,905:INFO: Experiment Progress: 0.8% -- 4/519
2018-05-10 12:17:10,867:INFO: Experiment Progress: 1.0% -- 5/519
2018-05-10 12:22:01,095:INFO: Experiment Progress: 1.2% -- 6/519
2018-05-10 12:26:49,116:INFO: Experiment Progress: 1.3% -- 7/519
2018-05-10 12:31:36,654:INFO: Experiment Progress: 1.5% -- 8/519
2018-05-10 12:36:26,233:INFO: Experiment Progress: 1.7% -- 9/519
2018-05-10 12:41:10,379:INFO: Experiment Progress: 1.9% -- 10/519
2018-05-10 12:45:59,047:INFO: Experiment Progress: 2.1% -- 11/519
2018-05-10 12:50:47,925:INFO: Experiment Progress: 2.3% -- 12/519
2018-05-10 12:55:13,347:INFO: Experiment Progress: 2.5% -- 13/519
2018-05-10 12:59:13,393:INFO: Experiment Progress: 2.7% -- 14/519
2018-05-10 13:03:14,530:INFO: Experiment Progress: 2.9% -- 15/519
2018-05-10 13:07:16,739:INFO: Experiment Progress: 3.1% -- 16/519
2018-05-10 13:11:16,858:INFO: Experiment Progress: 3.3% -- 17/519
2018-05-10 13:15:18,305:INFO: Experiment Progress: 3.5% -- 18/519
2018-05-10 13:19:19,458:INFO: Experiment Progress: 3.7% -- 19/519
2018-05-25 16:24:16,206:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 16:24:16,206:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 16:24:16,206:INFO: ======================================
2018-05-25 16:24:16,206:INFO: Loading PPI Network...
2018-05-25 16:24:23,331:INFO: Loading Disease Associations...
2018-05-25 16:24:23,383:INFO: Running Experiment...
2018-05-25 16:24:23,383:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 16:24:34,539:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:23:30,740:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:23:30,740:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:23:30,740:INFO: ======================================
2018-05-25 23:23:30,740:INFO: Loading PPI Network...
2018-05-25 23:23:37,853:INFO: Loading Disease Associations...
2018-05-25 23:23:37,867:INFO: Running Experiment...
2018-05-25 23:23:37,867:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:23:52,425:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:28:54,022:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:28:54,022:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:28:54,022:INFO: ======================================
2018-05-25 23:28:54,022:INFO: Loading PPI Network...
2018-05-25 23:29:01,532:INFO: Loading Disease Associations...
2018-05-25 23:29:01,546:INFO: Running Experiment...
2018-05-25 23:29:01,546:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:29:13,808:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:30:46,796:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:30:46,796:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:30:46,796:INFO: ======================================
2018-05-25 23:30:46,796:INFO: Loading PPI Network...
2018-05-25 23:30:53,974:INFO: Loading Disease Associations...
2018-05-25 23:30:53,988:INFO: Running Experiment...
2018-05-25 23:30:53,989:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:31:07,029:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:35:59,535:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:35:59,535:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:35:59,535:INFO: ======================================
2018-05-25 23:35:59,535:INFO: Loading PPI Network...
2018-05-25 23:36:06,776:INFO: Loading Disease Associations...
2018-05-25 23:36:06,791:INFO: Running Experiment...
2018-05-25 23:36:06,791:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:36:19,977:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:37:34,158:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:37:34,158:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:37:34,159:INFO: ======================================
2018-05-25 23:37:34,159:INFO: Loading PPI Network...
2018-05-25 23:37:41,377:INFO: Loading Disease Associations...
2018-05-25 23:37:41,410:INFO: Running Experiment...
2018-05-25 23:37:41,410:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:37:54,997:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:41:44,036:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:41:44,036:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:41:44,037:INFO: ======================================
2018-05-25 23:41:44,037:INFO: Loading PPI Network...
2018-05-25 23:41:51,631:INFO: Loading Disease Associations...
2018-05-25 23:41:51,646:INFO: Running Experiment...
2018-05-25 23:41:51,646:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:42:06,184:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:45:12,630:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:45:12,631:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:45:12,631:INFO: ======================================
2018-05-25 23:45:12,631:INFO: Loading PPI Network...
2018-05-25 23:45:20,417:INFO: Loading Disease Associations...
2018-05-25 23:45:20,431:INFO: Running Experiment...
2018-05-25 23:45:20,431:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:45:29,244:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:46:28,437:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:46:28,437:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:46:28,437:INFO: ======================================
2018-05-25 23:46:28,438:INFO: Loading PPI Network...
2018-05-25 23:46:35,605:INFO: Loading Disease Associations...
2018-05-25 23:46:35,620:INFO: Running Experiment...
2018-05-25 23:46:35,620:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:46:51,243:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-25 23:54:39,350:INFO: Disease Protein Prediction in the PPI Network
2018-05-25 23:54:39,351:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-25 23:54:39,351:INFO: ======================================
2018-05-25 23:54:39,351:INFO: Loading PPI Network...
2018-05-25 23:54:46,576:INFO: Loading Disease Associations...
2018-05-25 23:54:46,591:INFO: Running Experiment...
2018-05-25 23:54:46,591:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-25 23:55:02,120:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-26 00:00:31,841:INFO: Experiment Progress: 0.2% -- 1/519
2018-05-26 00:04:17,723:INFO: Experiment Progress: 0.4% -- 2/519
2018-05-26 00:08:00,888:INFO: Experiment Progress: 0.6% -- 3/519
2018-05-26 00:11:30,782:INFO: Experiment Progress: 0.8% -- 4/519
2018-05-26 00:15:16,478:INFO: Experiment Progress: 1.0% -- 5/519
2018-05-26 00:18:58,146:INFO: Experiment Progress: 1.2% -- 6/519
2018-05-26 00:22:38,821:INFO: Experiment Progress: 1.3% -- 7/519
2018-05-26 00:26:03,902:INFO: Experiment Progress: 1.5% -- 8/519
2018-05-26 00:29:14,978:INFO: Experiment Progress: 1.7% -- 9/519
2018-05-26 00:32:27,315:INFO: Experiment Progress: 1.9% -- 10/519
2018-05-26 00:36:03,562:INFO: Experiment Progress: 2.1% -- 11/519
2018-05-26 00:39:48,749:INFO: Experiment Progress: 2.3% -- 12/519
2018-05-26 00:43:34,801:INFO: Experiment Progress: 2.5% -- 13/519
2018-05-26 00:47:17,877:INFO: Experiment Progress: 2.7% -- 14/519
2018-05-26 00:51:02,022:INFO: Experiment Progress: 2.9% -- 15/519
2018-05-26 00:54:51,313:INFO: Experiment Progress: 3.1% -- 16/519
2018-05-26 00:58:36,537:INFO: Experiment Progress: 3.3% -- 17/519
2018-05-26 01:02:24,319:INFO: Experiment Progress: 3.5% -- 18/519
2018-05-26 01:06:01,839:INFO: Experiment Progress: 3.7% -- 19/519
2018-05-26 01:09:46,170:INFO: Experiment Progress: 3.9% -- 20/519
2018-05-26 01:13:31,933:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-26 01:17:16,155:INFO: Experiment Progress: 4.2% -- 22/519
2018-05-26 01:20:33,164:INFO: Experiment Progress: 4.4% -- 23/519
2018-05-26 01:23:28,968:INFO: Experiment Progress: 4.6% -- 24/519
2018-05-26 01:26:49,499:INFO: Experiment Progress: 4.8% -- 25/519
2018-05-26 01:30:36,110:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-26 01:34:18,923:INFO: Experiment Progress: 5.2% -- 27/519
2018-05-26 01:37:37,574:INFO: Experiment Progress: 5.4% -- 28/519
2018-05-26 01:40:38,832:INFO: Experiment Progress: 5.6% -- 29/519
2018-05-26 01:43:41,236:INFO: Experiment Progress: 5.8% -- 30/519
2018-05-26 01:46:54,750:INFO: Experiment Progress: 6.0% -- 31/519
2018-05-26 01:50:30,632:INFO: Experiment Progress: 6.2% -- 32/519
2018-05-26 01:53:44,920:INFO: Experiment Progress: 6.4% -- 33/519
2018-05-26 01:56:59,513:INFO: Experiment Progress: 6.6% -- 34/519
2018-05-26 02:00:15,803:INFO: Experiment Progress: 6.7% -- 35/519
2018-05-26 02:02:14,554:INFO: Experiment Progress: 6.9% -- 36/519
2018-05-26 02:05:22,269:INFO: Experiment Progress: 7.1% -- 37/519
2018-05-26 02:08:28,648:INFO: Experiment Progress: 7.3% -- 38/519
2018-05-26 02:11:37,282:INFO: Experiment Progress: 7.5% -- 39/519
2018-05-26 02:14:45,141:INFO: Experiment Progress: 7.7% -- 40/519
2018-05-26 02:17:55,046:INFO: Experiment Progress: 7.9% -- 41/519
2018-05-26 02:21:05,397:INFO: Experiment Progress: 8.1% -- 42/519
2018-05-26 02:24:10,481:INFO: Experiment Progress: 8.3% -- 43/519
2018-05-26 02:27:11,918:INFO: Experiment Progress: 8.5% -- 44/519
2018-05-26 02:30:11,018:INFO: Experiment Progress: 8.7% -- 45/519
2018-05-26 02:33:12,801:INFO: Experiment Progress: 8.9% -- 46/519
2018-05-26 02:36:15,830:INFO: Experiment Progress: 9.1% -- 47/519
2018-05-26 02:37:54,396:INFO: Experiment Progress: 9.2% -- 48/519
2018-05-26 02:41:03,906:INFO: Experiment Progress: 9.4% -- 49/519
2018-05-26 02:44:14,295:INFO: Experiment Progress: 9.6% -- 50/519
2018-05-26 02:47:25,698:INFO: Experiment Progress: 9.8% -- 51/519
2018-05-26 02:50:41,712:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-26 02:54:13,053:INFO: Experiment Progress: 10.2% -- 53/519
2018-05-26 02:57:31,533:INFO: Experiment Progress: 10.4% -- 54/519
2018-05-26 03:01:12,222:INFO: Experiment Progress: 10.6% -- 55/519
2018-05-26 03:04:38,732:INFO: Experiment Progress: 10.8% -- 56/519
2018-05-26 03:08:20,085:INFO: Experiment Progress: 11.0% -- 57/519
2018-05-26 03:12:03,191:INFO: Experiment Progress: 11.2% -- 58/519
2018-05-26 03:15:46,657:INFO: Experiment Progress: 11.4% -- 59/519
2018-05-26 03:19:07,497:INFO: Experiment Progress: 11.6% -- 60/519
2018-05-26 03:22:48,884:INFO: Experiment Progress: 11.8% -- 61/519
2018-05-26 03:26:23,729:INFO: Experiment Progress: 11.9% -- 62/519
2018-05-26 03:30:02,097:INFO: Experiment Progress: 12.1% -- 63/519
2018-05-26 03:33:32,465:INFO: Experiment Progress: 12.3% -- 64/519
2018-05-26 03:37:13,886:INFO: Experiment Progress: 12.5% -- 65/519
2018-05-26 03:41:00,136:INFO: Experiment Progress: 12.7% -- 66/519
2018-05-26 03:44:41,898:INFO: Experiment Progress: 12.9% -- 67/519
2018-05-26 03:48:26,921:INFO: Experiment Progress: 13.1% -- 68/519
2018-05-26 03:52:05,708:INFO: Experiment Progress: 13.3% -- 69/519
2018-05-26 03:55:12,130:INFO: Experiment Progress: 13.5% -- 70/519
2018-05-26 03:58:19,062:INFO: Experiment Progress: 13.7% -- 71/519
2018-05-26 04:01:21,373:INFO: Experiment Progress: 13.9% -- 72/519
2018-05-26 04:04:25,575:INFO: Experiment Progress: 14.1% -- 73/519
2018-05-26 04:07:31,272:INFO: Experiment Progress: 14.3% -- 74/519
2018-05-26 04:10:42,571:INFO: Experiment Progress: 14.5% -- 75/519
2018-05-26 04:14:03,690:INFO: Experiment Progress: 14.6% -- 76/519
2018-05-26 04:17:30,044:INFO: Experiment Progress: 14.8% -- 77/519
2018-05-26 04:21:15,727:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-26 04:24:53,290:INFO: Experiment Progress: 15.2% -- 79/519
2018-05-26 04:28:36,846:INFO: Experiment Progress: 15.4% -- 80/519
2018-05-26 04:32:19,988:INFO: Experiment Progress: 15.6% -- 81/519
2018-05-26 04:35:51,039:INFO: Experiment Progress: 15.8% -- 82/519
2018-05-26 04:39:12,025:INFO: Experiment Progress: 16.0% -- 83/519
2018-05-26 04:42:54,549:INFO: Experiment Progress: 16.2% -- 84/519
2018-05-26 04:46:23,546:INFO: Experiment Progress: 16.4% -- 85/519
2018-05-26 04:50:08,392:INFO: Experiment Progress: 16.6% -- 86/519
2018-05-26 04:53:38,412:INFO: Experiment Progress: 16.8% -- 87/519
2018-05-26 04:56:41,116:INFO: Experiment Progress: 17.0% -- 88/519
2018-05-26 04:59:30,415:INFO: Experiment Progress: 17.1% -- 89/519
2018-05-26 05:02:34,954:INFO: Experiment Progress: 17.3% -- 90/519
2018-05-26 05:05:04,656:INFO: Experiment Progress: 17.5% -- 91/519
2018-05-26 05:08:37,553:INFO: Experiment Progress: 17.7% -- 92/519
2018-05-26 05:12:13,489:INFO: Experiment Progress: 17.9% -- 93/519
2018-05-26 05:15:55,183:INFO: Experiment Progress: 18.1% -- 94/519
2018-05-26 05:19:23,769:INFO: Experiment Progress: 18.3% -- 95/519
2018-05-26 05:22:41,166:INFO: Experiment Progress: 18.5% -- 96/519
2018-05-26 05:26:03,726:INFO: Experiment Progress: 18.7% -- 97/519
2018-05-26 05:29:44,465:INFO: Experiment Progress: 18.9% -- 98/519
2018-05-26 05:33:25,624:INFO: Experiment Progress: 19.1% -- 99/519
2018-05-26 05:36:39,722:INFO: Experiment Progress: 19.3% -- 100/519
2018-05-26 05:39:55,300:INFO: Experiment Progress: 19.5% -- 101/519
2018-05-26 05:42:59,340:INFO: Experiment Progress: 19.7% -- 102/519
2018-05-26 05:45:42,971:INFO: Experiment Progress: 19.8% -- 103/519
2018-05-26 05:48:49,291:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-26 05:51:46,333:INFO: Experiment Progress: 20.2% -- 105/519
2018-05-26 05:54:50,098:INFO: Experiment Progress: 20.4% -- 106/519
2018-05-26 05:57:49,089:INFO: Experiment Progress: 20.6% -- 107/519
2018-05-26 06:00:53,194:INFO: Experiment Progress: 20.8% -- 108/519
2018-05-26 06:04:01,578:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-26 06:07:02,327:INFO: Experiment Progress: 21.2% -- 110/519
2018-05-26 06:10:18,780:INFO: Experiment Progress: 21.4% -- 111/519
2018-05-26 06:13:38,755:INFO: Experiment Progress: 21.6% -- 112/519
2018-05-26 06:17:16,893:INFO: Experiment Progress: 21.8% -- 113/519
2018-05-26 06:20:50,667:INFO: Experiment Progress: 22.0% -- 114/519
2018-05-26 06:24:09,352:INFO: Experiment Progress: 22.2% -- 115/519
2018-05-26 06:27:41,486:INFO: Experiment Progress: 22.4% -- 116/519
2018-05-26 06:31:19,016:INFO: Experiment Progress: 22.5% -- 117/519
2018-05-26 06:34:45,610:INFO: Experiment Progress: 22.7% -- 118/519
2018-05-26 06:37:46,271:INFO: Experiment Progress: 22.9% -- 119/519
2018-05-26 06:40:38,076:INFO: Experiment Progress: 23.1% -- 120/519
2018-05-26 06:43:20,724:INFO: Experiment Progress: 23.3% -- 121/519
2018-05-26 06:45:58,313:INFO: Experiment Progress: 23.5% -- 122/519
2018-05-26 06:48:25,248:INFO: Experiment Progress: 23.7% -- 123/519
2018-05-26 06:50:47,449:INFO: Experiment Progress: 23.9% -- 124/519
2018-05-26 06:53:04,785:INFO: Experiment Progress: 24.1% -- 125/519
2018-05-26 06:55:19,914:INFO: Experiment Progress: 24.3% -- 126/519
2018-05-26 06:57:31,122:INFO: Experiment Progress: 24.5% -- 127/519
2018-05-26 06:59:42,411:INFO: Experiment Progress: 24.7% -- 128/519
2018-05-26 07:01:52,388:INFO: Experiment Progress: 24.9% -- 129/519
2018-05-26 07:04:02,665:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-26 07:06:12,384:INFO: Experiment Progress: 25.2% -- 131/519
2018-05-26 07:08:22,627:INFO: Experiment Progress: 25.4% -- 132/519
2018-05-26 07:10:33,399:INFO: Experiment Progress: 25.6% -- 133/519
2018-05-26 07:12:44,735:INFO: Experiment Progress: 25.8% -- 134/519
2018-05-26 07:14:54,950:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-26 07:17:04,908:INFO: Experiment Progress: 26.2% -- 136/519
2018-05-26 07:19:16,390:INFO: Experiment Progress: 26.4% -- 137/519
2018-05-26 07:21:25,795:INFO: Experiment Progress: 26.6% -- 138/519
2018-05-26 07:23:36,733:INFO: Experiment Progress: 26.8% -- 139/519
2018-05-26 07:25:46,657:INFO: Experiment Progress: 27.0% -- 140/519
2018-05-26 07:27:57,531:INFO: Experiment Progress: 27.2% -- 141/519
2018-05-26 07:30:07,164:INFO: Experiment Progress: 27.4% -- 142/519
2018-05-26 07:32:17,959:INFO: Experiment Progress: 27.6% -- 143/519
2018-05-26 07:34:28,101:INFO: Experiment Progress: 27.7% -- 144/519
2018-05-26 07:36:40,281:INFO: Experiment Progress: 27.9% -- 145/519
2018-05-26 07:38:51,654:INFO: Experiment Progress: 28.1% -- 146/519
2018-05-26 07:41:02,007:INFO: Experiment Progress: 28.3% -- 147/519
2018-05-26 07:43:12,436:INFO: Experiment Progress: 28.5% -- 148/519
2018-05-26 07:45:22,857:INFO: Experiment Progress: 28.7% -- 149/519
2018-05-26 07:47:34,015:INFO: Experiment Progress: 28.9% -- 150/519
2018-05-26 07:49:44,276:INFO: Experiment Progress: 29.1% -- 151/519
2018-05-26 07:51:54,301:INFO: Experiment Progress: 29.3% -- 152/519
2018-05-26 07:54:04,291:INFO: Experiment Progress: 29.5% -- 153/519
2018-05-26 07:56:15,401:INFO: Experiment Progress: 29.7% -- 154/519
2018-05-26 07:58:25,083:INFO: Experiment Progress: 29.9% -- 155/519
2018-05-26 08:00:36,305:INFO: Experiment Progress: 30.1% -- 156/519
2018-05-26 08:02:47,927:INFO: Experiment Progress: 30.3% -- 157/519
2018-05-26 08:05:00,747:INFO: Experiment Progress: 30.4% -- 158/519
2018-05-26 08:07:11,840:INFO: Experiment Progress: 30.6% -- 159/519
2018-05-26 08:09:23,143:INFO: Experiment Progress: 30.8% -- 160/519
2018-05-26 08:11:32,862:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-26 08:13:44,913:INFO: Experiment Progress: 31.2% -- 162/519
2018-05-26 08:15:56,733:INFO: Experiment Progress: 31.4% -- 163/519
2018-05-26 08:18:08,935:INFO: Experiment Progress: 31.6% -- 164/519
2018-05-26 08:20:21,390:INFO: Experiment Progress: 31.8% -- 165/519
2018-05-26 08:22:33,674:INFO: Experiment Progress: 32.0% -- 166/519
2018-05-26 08:24:45,206:INFO: Experiment Progress: 32.2% -- 167/519
2018-05-26 08:26:55,675:INFO: Experiment Progress: 32.4% -- 168/519
2018-05-26 08:29:05,609:INFO: Experiment Progress: 32.6% -- 169/519
2018-05-26 08:31:15,693:INFO: Experiment Progress: 32.8% -- 170/519
2018-05-26 08:33:26,414:INFO: Experiment Progress: 32.9% -- 171/519
2018-05-26 08:35:35,878:INFO: Experiment Progress: 33.1% -- 172/519
2018-05-26 08:37:46,104:INFO: Experiment Progress: 33.3% -- 173/519
2018-05-26 08:39:56,566:INFO: Experiment Progress: 33.5% -- 174/519
2018-05-26 08:42:07,828:INFO: Experiment Progress: 33.7% -- 175/519
2018-05-26 08:44:18,928:INFO: Experiment Progress: 33.9% -- 176/519
2018-05-26 08:46:30,678:INFO: Experiment Progress: 34.1% -- 177/519
2018-05-26 08:48:40,683:INFO: Experiment Progress: 34.3% -- 178/519
2018-05-26 08:50:37,752:INFO: Experiment Progress: 34.5% -- 179/519
2018-05-26 08:52:48,029:INFO: Experiment Progress: 34.7% -- 180/519
2018-05-26 08:54:58,398:INFO: Experiment Progress: 34.9% -- 181/519
2018-05-26 08:57:08,148:INFO: Experiment Progress: 35.1% -- 182/519
2018-05-26 08:59:18,965:INFO: Experiment Progress: 35.3% -- 183/519
2018-05-26 09:01:27,992:INFO: Experiment Progress: 35.5% -- 184/519
2018-05-26 09:03:38,049:INFO: Experiment Progress: 35.6% -- 185/519
2018-05-26 09:05:47,731:INFO: Experiment Progress: 35.8% -- 186/519
2018-05-26 09:07:59,726:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-26 09:10:10,574:INFO: Experiment Progress: 36.2% -- 188/519
2018-05-26 09:12:22,047:INFO: Experiment Progress: 36.4% -- 189/519
2018-05-26 09:14:32,019:INFO: Experiment Progress: 36.6% -- 190/519
2018-05-26 09:16:43,174:INFO: Experiment Progress: 36.8% -- 191/519
2018-05-26 09:18:54,892:INFO: Experiment Progress: 37.0% -- 192/519
2018-05-26 09:21:05,459:INFO: Experiment Progress: 37.2% -- 193/519
2018-05-26 09:23:16,196:INFO: Experiment Progress: 37.4% -- 194/519
2018-05-26 09:25:28,617:INFO: Experiment Progress: 37.6% -- 195/519
2018-05-26 09:27:42,635:INFO: Experiment Progress: 37.8% -- 196/519
2018-05-26 09:29:59,163:INFO: Experiment Progress: 38.0% -- 197/519
2018-05-26 09:32:15,074:INFO: Experiment Progress: 38.2% -- 198/519
2018-05-26 09:34:32,924:INFO: Experiment Progress: 38.3% -- 199/519
2018-05-26 09:36:53,888:INFO: Experiment Progress: 38.5% -- 200/519
2018-05-26 09:39:12,876:INFO: Experiment Progress: 38.7% -- 201/519
2018-05-26 09:41:32,827:INFO: Experiment Progress: 38.9% -- 202/519
2018-05-26 09:43:51,200:INFO: Experiment Progress: 39.1% -- 203/519
2018-05-26 09:46:10,926:INFO: Experiment Progress: 39.3% -- 204/519
2018-05-26 09:48:29,980:INFO: Experiment Progress: 39.5% -- 205/519
2018-05-26 09:50:50,066:INFO: Experiment Progress: 39.7% -- 206/519
2018-05-26 09:53:09,411:INFO: Experiment Progress: 39.9% -- 207/519
2018-05-26 09:55:28,909:INFO: Experiment Progress: 40.1% -- 208/519
2018-05-26 09:57:47,750:INFO: Experiment Progress: 40.3% -- 209/519
2018-05-26 10:00:06,365:INFO: Experiment Progress: 40.5% -- 210/519
2018-05-26 10:02:25,637:INFO: Experiment Progress: 40.7% -- 211/519
2018-05-26 10:04:43,404:INFO: Experiment Progress: 40.8% -- 212/519
2018-05-26 10:07:02,524:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-26 10:09:19,037:INFO: Experiment Progress: 41.2% -- 214/519
2018-05-26 10:11:36,791:INFO: Experiment Progress: 41.4% -- 215/519
2018-05-26 10:13:52,480:INFO: Experiment Progress: 41.6% -- 216/519
2018-05-26 10:16:08,345:INFO: Experiment Progress: 41.8% -- 217/519
2018-05-26 10:18:23,378:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-26 10:20:37,980:INFO: Experiment Progress: 42.2% -- 219/519
2018-05-26 10:22:25,225:INFO: Experiment Progress: 42.4% -- 220/519
2018-05-26 10:24:39,947:INFO: Experiment Progress: 42.6% -- 221/519
2018-05-26 10:26:54,534:INFO: Experiment Progress: 42.8% -- 222/519
2018-05-26 10:28:54,895:INFO: Experiment Progress: 43.0% -- 223/519
2018-05-26 10:31:09,856:INFO: Experiment Progress: 43.2% -- 224/519
2018-05-26 10:33:25,236:INFO: Experiment Progress: 43.4% -- 225/519
2018-05-26 10:35:40,705:INFO: Experiment Progress: 43.5% -- 226/519
2018-05-26 10:37:59,296:INFO: Experiment Progress: 43.7% -- 227/519
2018-05-26 10:40:18,616:INFO: Experiment Progress: 43.9% -- 228/519
2018-05-26 10:42:37,154:INFO: Experiment Progress: 44.1% -- 229/519
2018-05-26 10:44:57,347:INFO: Experiment Progress: 44.3% -- 230/519
2018-05-26 10:47:16,489:INFO: Experiment Progress: 44.5% -- 231/519
2018-05-26 10:49:37,353:INFO: Experiment Progress: 44.7% -- 232/519
2018-05-26 10:51:56,397:INFO: Experiment Progress: 44.9% -- 233/519
2018-05-26 10:54:16,739:INFO: Experiment Progress: 45.1% -- 234/519
2018-05-26 10:56:35,910:INFO: Experiment Progress: 45.3% -- 235/519
2018-05-26 10:58:54,793:INFO: Experiment Progress: 45.5% -- 236/519
2018-05-26 11:01:13,074:INFO: Experiment Progress: 45.7% -- 237/519
2018-05-26 11:03:30,073:INFO: Experiment Progress: 45.9% -- 238/519
2018-05-26 11:05:50,003:INFO: Experiment Progress: 46.1% -- 239/519
2018-05-26 11:08:09,497:INFO: Experiment Progress: 46.2% -- 240/519
2018-05-26 11:10:28,567:INFO: Experiment Progress: 46.4% -- 241/519
2018-05-26 11:12:48,383:INFO: Experiment Progress: 46.6% -- 242/519
2018-05-26 11:15:09,330:INFO: Experiment Progress: 46.8% -- 243/519
2018-05-26 11:17:28,116:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-26 11:19:48,761:INFO: Experiment Progress: 47.2% -- 245/519
2018-05-26 11:22:08,859:INFO: Experiment Progress: 47.4% -- 246/519
2018-05-26 11:24:27,644:INFO: Experiment Progress: 47.6% -- 247/519
2018-05-26 11:26:47,244:INFO: Experiment Progress: 47.8% -- 248/519
2018-05-26 11:29:06,872:INFO: Experiment Progress: 48.0% -- 249/519
2018-05-26 11:31:22,600:INFO: Experiment Progress: 48.2% -- 250/519
2018-05-26 11:33:37,836:INFO: Experiment Progress: 48.4% -- 251/519
2018-05-26 11:35:52,310:INFO: Experiment Progress: 48.6% -- 252/519
2018-05-26 11:38:09,253:INFO: Experiment Progress: 48.7% -- 253/519
2018-05-26 11:39:59,648:INFO: Experiment Progress: 48.9% -- 254/519
2018-05-26 11:42:17,367:INFO: Experiment Progress: 49.1% -- 255/519
2018-05-26 11:44:36,880:INFO: Experiment Progress: 49.3% -- 256/519
2018-05-26 11:46:56,405:INFO: Experiment Progress: 49.5% -- 257/519
2018-05-26 11:49:16,428:INFO: Experiment Progress: 49.7% -- 258/519
2018-05-26 11:51:37,438:INFO: Experiment Progress: 49.9% -- 259/519
2018-05-26 11:53:01,951:INFO: Experiment Progress: 50.1% -- 260/519
2018-05-26 11:55:24,492:INFO: Experiment Progress: 50.3% -- 261/519
2018-05-26 11:57:48,544:INFO: Experiment Progress: 50.5% -- 262/519
2018-05-26 12:00:12,057:INFO: Experiment Progress: 50.7% -- 263/519
2018-05-26 12:02:36,958:INFO: Experiment Progress: 50.9% -- 264/519
2018-05-26 12:04:46,673:INFO: Experiment Progress: 51.1% -- 265/519
2018-05-26 12:07:09,640:INFO: Experiment Progress: 51.3% -- 266/519
2018-05-26 12:09:03,950:INFO: Experiment Progress: 51.4% -- 267/519
2018-05-26 12:11:28,422:INFO: Experiment Progress: 51.6% -- 268/519
2018-05-26 12:13:52,608:INFO: Experiment Progress: 51.8% -- 269/519
2018-05-26 12:16:16,315:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-26 12:18:41,045:INFO: Experiment Progress: 52.2% -- 271/519
2018-05-26 12:21:05,818:INFO: Experiment Progress: 52.4% -- 272/519
2018-05-26 12:23:32,975:INFO: Experiment Progress: 52.6% -- 273/519
2018-05-26 12:26:01,307:INFO: Experiment Progress: 52.8% -- 274/519
2018-05-26 12:28:31,119:INFO: Experiment Progress: 53.0% -- 275/519
2018-05-26 12:31:01,856:INFO: Experiment Progress: 53.2% -- 276/519
2018-05-26 12:33:33,393:INFO: Experiment Progress: 53.4% -- 277/519
2018-05-26 12:36:02,581:INFO: Experiment Progress: 53.6% -- 278/519
2018-05-26 12:38:33,375:INFO: Experiment Progress: 53.8% -- 279/519
2018-05-26 12:40:17,808:INFO: Experiment Progress: 53.9% -- 280/519
2018-05-26 12:42:50,248:INFO: Experiment Progress: 54.1% -- 281/519
2018-05-26 12:45:24,890:INFO: Experiment Progress: 54.3% -- 282/519
2018-05-26 12:46:57,311:INFO: Experiment Progress: 54.5% -- 283/519
2018-05-26 12:49:29,391:INFO: Experiment Progress: 54.7% -- 284/519
2018-05-26 12:52:03,833:INFO: Experiment Progress: 54.9% -- 285/519
2018-05-26 12:56:46,992:INFO: Experiment Progress: 55.1% -- 286/519
2018-05-26 13:23:50,661:INFO: Experiment Progress: 55.3% -- 287/519
2018-05-26 13:52:04,907:INFO: Experiment Progress: 55.5% -- 288/519
2018-05-26 14:16:04,023:INFO: Experiment Progress: 55.7% -- 289/519
2018-05-26 14:36:12,204:INFO: Experiment Progress: 55.9% -- 290/519
2018-05-26 14:52:03,854:INFO: Experiment Progress: 56.1% -- 291/519
2018-05-26 15:21:07,910:INFO: Experiment Progress: 56.3% -- 292/519
2018-05-26 15:45:12,670:INFO: Experiment Progress: 56.5% -- 293/519
2018-05-26 15:55:08,550:INFO: Experiment Progress: 56.6% -- 294/519
2018-05-26 16:05:38,344:INFO: Experiment Progress: 56.8% -- 295/519
2018-05-26 16:20:00,297:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-26 16:33:37,814:INFO: Experiment Progress: 57.2% -- 297/519
2018-05-26 16:54:20,722:INFO: Experiment Progress: 57.4% -- 298/519
2018-05-26 17:01:00,150:INFO: Experiment Progress: 57.6% -- 299/519
2018-05-26 17:03:58,139:INFO: Experiment Progress: 57.8% -- 300/519
2018-05-26 17:07:01,230:INFO: Experiment Progress: 58.0% -- 301/519
2018-05-26 17:10:06,777:INFO: Experiment Progress: 58.2% -- 302/519
2018-05-26 17:13:11,300:INFO: Experiment Progress: 58.4% -- 303/519
2018-05-26 17:16:18,566:INFO: Experiment Progress: 58.6% -- 304/519
2018-05-26 17:19:31,513:INFO: Experiment Progress: 58.8% -- 305/519
2018-05-26 17:22:47,714:INFO: Experiment Progress: 59.0% -- 306/519
2018-05-26 17:26:23,826:INFO: Experiment Progress: 59.2% -- 307/519
2018-05-26 17:29:58,895:INFO: Experiment Progress: 59.3% -- 308/519
2018-05-26 17:33:29,431:INFO: Experiment Progress: 59.5% -- 309/519
2018-05-26 17:36:41,228:INFO: Experiment Progress: 59.7% -- 310/519
2018-05-26 17:39:54,783:INFO: Experiment Progress: 59.9% -- 311/519
2018-05-26 17:43:11,077:INFO: Experiment Progress: 60.1% -- 312/519
2018-05-26 17:46:37,312:INFO: Experiment Progress: 60.3% -- 313/519
2018-05-26 17:49:57,218:INFO: Experiment Progress: 60.5% -- 314/519
2018-05-26 17:53:04,143:INFO: Experiment Progress: 60.7% -- 315/519
2018-05-26 17:56:25,827:INFO: Experiment Progress: 60.9% -- 316/519
2018-05-26 17:59:41,096:INFO: Experiment Progress: 61.1% -- 317/519
2018-05-26 18:02:46,100:INFO: Experiment Progress: 61.3% -- 318/519
2018-05-26 18:06:03,942:INFO: Experiment Progress: 61.5% -- 319/519
2018-05-26 18:09:18,126:INFO: Experiment Progress: 61.7% -- 320/519
2018-05-26 18:12:36,607:INFO: Experiment Progress: 61.8% -- 321/519
2018-05-26 18:15:50,185:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-26 18:19:03,808:INFO: Experiment Progress: 62.2% -- 323/519
2018-05-26 18:22:17,447:INFO: Experiment Progress: 62.4% -- 324/519
2018-05-26 18:25:33,055:INFO: Experiment Progress: 62.6% -- 325/519
2018-05-26 18:28:53,754:INFO: Experiment Progress: 62.8% -- 326/519
2018-05-26 18:32:03,726:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-26 18:35:20,061:INFO: Experiment Progress: 63.2% -- 328/519
2018-05-26 18:38:38,997:INFO: Experiment Progress: 63.4% -- 329/519
2018-05-26 18:41:54,093:INFO: Experiment Progress: 63.6% -- 330/519
2018-05-26 18:45:07,665:INFO: Experiment Progress: 63.8% -- 331/519
2018-05-26 18:48:22,595:INFO: Experiment Progress: 64.0% -- 332/519
2018-05-26 18:51:43,883:INFO: Experiment Progress: 64.2% -- 333/519
2018-05-26 18:55:03,935:INFO: Experiment Progress: 64.4% -- 334/519
2018-05-26 18:58:22,884:INFO: Experiment Progress: 64.5% -- 335/519
2018-05-26 19:01:44,454:INFO: Experiment Progress: 64.7% -- 336/519
2018-05-26 19:04:53,817:INFO: Experiment Progress: 64.9% -- 337/519
2018-05-26 19:08:04,101:INFO: Experiment Progress: 65.1% -- 338/519
2018-05-26 19:11:18,764:INFO: Experiment Progress: 65.3% -- 339/519
2018-05-26 19:14:27,647:INFO: Experiment Progress: 65.5% -- 340/519
2018-05-26 19:17:45,549:INFO: Experiment Progress: 65.7% -- 341/519
2018-05-26 19:21:11,132:INFO: Experiment Progress: 65.9% -- 342/519
2018-05-26 19:24:29,861:INFO: Experiment Progress: 66.1% -- 343/519
2018-05-26 19:27:39,348:INFO: Experiment Progress: 66.3% -- 344/519
2018-05-26 19:30:49,757:INFO: Experiment Progress: 66.5% -- 345/519
2018-05-26 19:34:05,768:INFO: Experiment Progress: 66.7% -- 346/519
2018-05-26 19:37:07,966:INFO: Experiment Progress: 66.9% -- 347/519
2018-05-26 19:40:15,058:INFO: Experiment Progress: 67.1% -- 348/519
2018-05-26 19:43:23,200:INFO: Experiment Progress: 67.2% -- 349/519
2018-05-26 19:46:26,349:INFO: Experiment Progress: 67.4% -- 350/519
2018-05-26 19:49:41,988:INFO: Experiment Progress: 67.6% -- 351/519
2018-05-26 19:52:59,039:INFO: Experiment Progress: 67.8% -- 352/519
2018-05-26 19:56:14,122:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-26 19:59:27,401:INFO: Experiment Progress: 68.2% -- 354/519
2018-05-26 20:02:48,820:INFO: Experiment Progress: 68.4% -- 355/519
2018-05-26 20:06:03,877:INFO: Experiment Progress: 68.6% -- 356/519
2018-05-26 20:09:07,190:INFO: Experiment Progress: 68.8% -- 357/519
2018-05-26 20:12:24,330:INFO: Experiment Progress: 69.0% -- 358/519
2018-05-26 20:15:36,030:INFO: Experiment Progress: 69.2% -- 359/519
2018-05-26 20:18:46,369:INFO: Experiment Progress: 69.4% -- 360/519
2018-05-26 20:21:57,836:INFO: Experiment Progress: 69.6% -- 361/519
2018-05-26 20:25:10,430:INFO: Experiment Progress: 69.7% -- 362/519
2018-05-26 20:28:30,084:INFO: Experiment Progress: 69.9% -- 363/519
2018-05-26 20:31:45,207:INFO: Experiment Progress: 70.1% -- 364/519
2018-05-26 20:34:56,764:INFO: Experiment Progress: 70.3% -- 365/519
2018-05-26 20:37:45,431:INFO: Experiment Progress: 70.5% -- 366/519
2018-05-26 20:40:45,507:INFO: Experiment Progress: 70.7% -- 367/519
2018-05-26 20:43:49,551:INFO: Experiment Progress: 70.9% -- 368/519
2018-05-26 20:46:58,185:INFO: Experiment Progress: 71.1% -- 369/519
2018-05-26 20:50:16,224:INFO: Experiment Progress: 71.3% -- 370/519
2018-05-26 20:53:34,338:INFO: Experiment Progress: 71.5% -- 371/519
2018-05-26 20:56:39,492:INFO: Experiment Progress: 71.7% -- 372/519
2018-05-26 21:00:09,468:INFO: Experiment Progress: 71.9% -- 373/519
2018-05-26 21:03:33,608:INFO: Experiment Progress: 72.1% -- 374/519
2018-05-26 21:06:57,544:INFO: Experiment Progress: 72.3% -- 375/519
2018-05-26 21:10:14,777:INFO: Experiment Progress: 72.4% -- 376/519
2018-05-26 21:13:27,800:INFO: Experiment Progress: 72.6% -- 377/519
2018-05-26 21:16:51,849:INFO: Experiment Progress: 72.8% -- 378/519
2018-05-26 21:20:25,370:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-26 21:23:43,414:INFO: Experiment Progress: 73.2% -- 380/519
2018-05-26 21:27:09,656:INFO: Experiment Progress: 73.4% -- 381/519
2018-05-26 21:30:37,768:INFO: Experiment Progress: 73.6% -- 382/519
2018-05-26 21:33:50,006:INFO: Experiment Progress: 73.8% -- 383/519
2018-05-26 21:37:05,677:INFO: Experiment Progress: 74.0% -- 384/519
2018-05-26 21:40:25,993:INFO: Experiment Progress: 74.2% -- 385/519
2018-05-26 21:43:33,472:INFO: Experiment Progress: 74.4% -- 386/519
2018-05-26 21:46:49,501:INFO: Experiment Progress: 74.6% -- 387/519
2018-05-26 21:50:09,966:INFO: Experiment Progress: 74.8% -- 388/519
2018-05-26 21:53:45,511:INFO: Experiment Progress: 75.0% -- 389/519
2018-05-26 21:57:26,866:INFO: Experiment Progress: 75.1% -- 390/519
2018-05-26 22:01:01,488:INFO: Experiment Progress: 75.3% -- 391/519
2018-05-26 22:04:19,897:INFO: Experiment Progress: 75.5% -- 392/519
2018-05-26 22:07:26,041:INFO: Experiment Progress: 75.7% -- 393/519
2018-05-26 22:10:26,064:INFO: Experiment Progress: 75.9% -- 394/519
2018-05-26 22:13:27,674:INFO: Experiment Progress: 76.1% -- 395/519
2018-05-26 22:16:33,589:INFO: Experiment Progress: 76.3% -- 396/519
2018-05-26 22:19:36,075:INFO: Experiment Progress: 76.5% -- 397/519
2018-05-26 22:22:34,241:INFO: Experiment Progress: 76.7% -- 398/519
2018-05-26 22:25:37,143:INFO: Experiment Progress: 76.9% -- 399/519
2018-05-26 22:28:40,435:INFO: Experiment Progress: 77.1% -- 400/519
2018-05-26 22:31:44,029:INFO: Experiment Progress: 77.3% -- 401/519
2018-05-26 22:34:48,306:INFO: Experiment Progress: 77.5% -- 402/519
2018-05-26 22:37:47,168:INFO: Experiment Progress: 77.6% -- 403/519
2018-05-26 22:40:31,201:INFO: Experiment Progress: 77.8% -- 404/519
2018-05-26 22:43:33,105:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-26 22:46:34,326:INFO: Experiment Progress: 78.2% -- 406/519
2018-05-26 22:49:28,917:INFO: Experiment Progress: 78.4% -- 407/519
2018-05-26 22:52:22,975:INFO: Experiment Progress: 78.6% -- 408/519
2018-05-26 22:55:22,022:INFO: Experiment Progress: 78.8% -- 409/519
2018-05-26 22:58:19,371:INFO: Experiment Progress: 79.0% -- 410/519
2018-05-26 23:01:14,483:INFO: Experiment Progress: 79.2% -- 411/519
2018-05-26 23:04:08,961:INFO: Experiment Progress: 79.4% -- 412/519
2018-05-26 23:07:06,669:INFO: Experiment Progress: 79.6% -- 413/519
2018-05-26 23:10:01,329:INFO: Experiment Progress: 79.8% -- 414/519
2018-05-26 23:12:58,208:INFO: Experiment Progress: 80.0% -- 415/519
2018-05-26 23:15:49,519:INFO: Experiment Progress: 80.2% -- 416/519
2018-05-26 23:18:43,291:INFO: Experiment Progress: 80.3% -- 417/519
2018-05-26 23:21:34,268:INFO: Experiment Progress: 80.5% -- 418/519
2018-05-26 23:24:25,520:INFO: Experiment Progress: 80.7% -- 419/519
2018-05-26 23:27:11,835:INFO: Experiment Progress: 80.9% -- 420/519
2018-05-26 23:30:09,617:INFO: Experiment Progress: 81.1% -- 421/519
2018-05-26 23:33:04,197:INFO: Experiment Progress: 81.3% -- 422/519
2018-05-26 23:35:59,469:INFO: Experiment Progress: 81.5% -- 423/519
2018-05-26 23:38:55,493:INFO: Experiment Progress: 81.7% -- 424/519
2018-05-26 23:41:45,867:INFO: Experiment Progress: 81.9% -- 425/519
2018-05-26 23:44:41,618:INFO: Experiment Progress: 82.1% -- 426/519
2018-05-26 23:47:36,693:INFO: Experiment Progress: 82.3% -- 427/519
2018-05-26 23:50:31,646:INFO: Experiment Progress: 82.5% -- 428/519
2018-05-26 23:53:21,894:INFO: Experiment Progress: 82.7% -- 429/519
2018-05-26 23:56:14,317:INFO: Experiment Progress: 82.9% -- 430/519
2018-05-26 23:59:05,851:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-27 00:01:55,495:INFO: Experiment Progress: 83.2% -- 432/519
2018-05-27 00:04:44,558:INFO: Experiment Progress: 83.4% -- 433/519
2018-05-27 00:07:32,525:INFO: Experiment Progress: 83.6% -- 434/519
2018-05-27 00:10:22,191:INFO: Experiment Progress: 83.8% -- 435/519
2018-05-27 00:13:08,237:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-27 00:15:58,413:INFO: Experiment Progress: 84.2% -- 437/519
2018-05-27 00:18:46,908:INFO: Experiment Progress: 84.4% -- 438/519
2018-05-27 00:21:34,225:INFO: Experiment Progress: 84.6% -- 439/519
2018-05-27 00:24:21,135:INFO: Experiment Progress: 84.8% -- 440/519
2018-05-27 00:27:08,971:INFO: Experiment Progress: 85.0% -- 441/519
2018-05-27 00:30:00,801:INFO: Experiment Progress: 85.2% -- 442/519
2018-05-27 00:32:54,358:INFO: Experiment Progress: 85.4% -- 443/519
2018-05-27 00:35:51,223:INFO: Experiment Progress: 85.5% -- 444/519
2018-05-27 00:38:48,869:INFO: Experiment Progress: 85.7% -- 445/519
2018-05-27 00:41:45,009:INFO: Experiment Progress: 85.9% -- 446/519
2018-05-27 00:44:40,146:INFO: Experiment Progress: 86.1% -- 447/519
2018-05-27 00:47:35,078:INFO: Experiment Progress: 86.3% -- 448/519
2018-05-27 00:50:33,286:INFO: Experiment Progress: 86.5% -- 449/519
2018-05-27 00:53:32,157:INFO: Experiment Progress: 86.7% -- 450/519
2018-05-27 00:56:31,765:INFO: Experiment Progress: 86.9% -- 451/519
2018-05-27 00:59:29,016:INFO: Experiment Progress: 87.1% -- 452/519
2018-05-27 01:02:23,775:INFO: Experiment Progress: 87.3% -- 453/519
2018-05-27 01:05:23,311:INFO: Experiment Progress: 87.5% -- 454/519
2018-05-27 01:08:16,874:INFO: Experiment Progress: 87.7% -- 455/519
2018-05-27 01:11:12,411:INFO: Experiment Progress: 87.9% -- 456/519
2018-05-27 01:14:07,409:INFO: Experiment Progress: 88.1% -- 457/519
2018-05-27 01:17:02,020:INFO: Experiment Progress: 88.2% -- 458/519
2018-05-27 01:19:58,059:INFO: Experiment Progress: 88.4% -- 459/519
2018-05-27 01:22:53,186:INFO: Experiment Progress: 88.6% -- 460/519
2018-05-27 01:25:48,644:INFO: Experiment Progress: 88.8% -- 461/519
2018-05-27 01:28:39,342:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-27 01:31:29,227:INFO: Experiment Progress: 89.2% -- 463/519
2018-05-27 01:34:21,190:INFO: Experiment Progress: 89.4% -- 464/519
2018-05-27 01:37:12,338:INFO: Experiment Progress: 89.6% -- 465/519
2018-05-27 01:40:02,846:INFO: Experiment Progress: 89.8% -- 466/519
2018-05-27 01:42:54,845:INFO: Experiment Progress: 90.0% -- 467/519
2018-05-27 01:45:46,817:INFO: Experiment Progress: 90.2% -- 468/519
2018-05-27 01:48:37,544:INFO: Experiment Progress: 90.4% -- 469/519
2018-05-27 01:51:28,025:INFO: Experiment Progress: 90.6% -- 470/519
2018-05-27 01:54:18,998:INFO: Experiment Progress: 90.8% -- 471/519
2018-05-27 01:57:08,602:INFO: Experiment Progress: 90.9% -- 472/519
2018-05-27 01:59:59,471:INFO: Experiment Progress: 91.1% -- 473/519
2018-05-27 02:02:49,490:INFO: Experiment Progress: 91.3% -- 474/519
2018-05-27 02:05:41,382:INFO: Experiment Progress: 91.5% -- 475/519
2018-05-27 02:08:29,755:INFO: Experiment Progress: 91.7% -- 476/519
2018-05-27 02:11:15,308:INFO: Experiment Progress: 91.9% -- 477/519
2018-05-27 02:14:06,712:INFO: Experiment Progress: 92.1% -- 478/519
2018-05-27 02:16:56,595:INFO: Experiment Progress: 92.3% -- 479/519
2018-05-27 02:19:43,259:INFO: Experiment Progress: 92.5% -- 480/519
2018-05-27 02:22:27,149:INFO: Experiment Progress: 92.7% -- 481/519
2018-05-27 02:25:20,056:INFO: Experiment Progress: 92.9% -- 482/519
2018-05-27 02:28:11,819:INFO: Experiment Progress: 93.1% -- 483/519
2018-05-27 02:31:07,395:INFO: Experiment Progress: 93.3% -- 484/519
2018-05-27 02:34:02,013:INFO: Experiment Progress: 93.4% -- 485/519
2018-05-27 02:36:56,219:INFO: Experiment Progress: 93.6% -- 486/519
2018-05-27 02:39:49,907:INFO: Experiment Progress: 93.8% -- 487/519
2018-05-27 02:42:39,666:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-27 02:45:29,122:INFO: Experiment Progress: 94.2% -- 489/519
2018-05-27 02:48:23,023:INFO: Experiment Progress: 94.4% -- 490/519
2018-05-27 02:51:15,137:INFO: Experiment Progress: 94.6% -- 491/519
2018-05-27 02:54:07,209:INFO: Experiment Progress: 94.8% -- 492/519
2018-05-27 02:56:58,099:INFO: Experiment Progress: 95.0% -- 493/519
2018-05-27 02:59:50,333:INFO: Experiment Progress: 95.2% -- 494/519
2018-05-27 03:02:42,649:INFO: Experiment Progress: 95.4% -- 495/519
2018-05-27 03:05:35,024:INFO: Experiment Progress: 95.6% -- 496/519
2018-05-27 03:08:18,758:INFO: Experiment Progress: 95.8% -- 497/519
2018-05-27 03:11:03,642:INFO: Experiment Progress: 96.0% -- 498/519
2018-05-27 03:13:51,126:INFO: Experiment Progress: 96.1% -- 499/519
2018-05-27 03:16:39,015:INFO: Experiment Progress: 96.3% -- 500/519
2018-05-27 03:19:22,739:INFO: Experiment Progress: 96.5% -- 501/519
2018-05-27 03:22:10,577:INFO: Experiment Progress: 96.7% -- 502/519
2018-05-27 03:24:59,977:INFO: Experiment Progress: 96.9% -- 503/519
2018-05-27 03:27:49,832:INFO: Experiment Progress: 97.1% -- 504/519
2018-05-27 03:30:36,187:INFO: Experiment Progress: 97.3% -- 505/519
2018-05-27 03:33:25,953:INFO: Experiment Progress: 97.5% -- 506/519
2018-05-27 03:36:18,105:INFO: Experiment Progress: 97.7% -- 507/519
2018-05-27 03:39:12,946:INFO: Experiment Progress: 97.9% -- 508/519
2018-05-27 03:42:08,333:INFO: Experiment Progress: 98.1% -- 509/519
2018-05-27 03:45:02,252:INFO: Experiment Progress: 98.3% -- 510/519
2018-05-27 03:47:58,839:INFO: Experiment Progress: 98.5% -- 511/519
2018-05-27 03:50:59,957:INFO: Experiment Progress: 98.7% -- 512/519
2018-05-27 03:54:02,634:INFO: Experiment Progress: 98.8% -- 513/519
2018-05-27 03:57:06,195:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-27 04:00:07,428:INFO: Experiment Progress: 99.2% -- 515/519
2018-05-27 04:03:11,739:INFO: Experiment Progress: 99.4% -- 516/519
2018-05-27 04:06:10,568:INFO: Experiment Progress: 99.6% -- 517/519
2018-05-27 04:09:11,385:INFO: Experiment Progress: 99.8% -- 518/519
2018-05-27 16:19:16,929:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 16:19:16,929:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 16:19:16,930:INFO: ======================================
2018-05-27 16:19:16,930:INFO: Loading PPI Network...
2018-05-27 16:19:26,085:INFO: Loading Disease Associations...
2018-05-27 16:19:35,872:INFO: Running Experiment...
2018-05-27 16:19:35,872:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 16:19:36,072:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 16:20:24,892:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 30.00%
2018-05-27 16:20:24,892:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 16:21:09,002:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 16:21:09,003:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 16:21:54,230:INFO: Zellweger Syndrome Recall-at-100: 80.00%
2018-05-27 16:21:54,231:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 16:22:40,860:INFO: Psoriasis Recall-at-100: 10.95%
2018-05-27 16:22:40,861:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 16:23:26,674:INFO: Nephrotic Syndrome Recall-at-100: 8.33%
2018-05-27 16:23:26,675:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 16:24:12,187:INFO: Nephrosis Recall-at-100: 10.00%
2018-05-27 16:24:12,188:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 16:24:58,593:INFO: Mouth Diseases Recall-at-100: 10.00%
2018-05-27 16:24:58,594:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 16:25:45,862:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-27 16:25:45,862:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 16:26:32,331:INFO: Substance-Related Disorders Recall-at-100: 2.91%
2018-05-27 16:26:32,332:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 16:27:18,203:INFO: Anemia, Hemolytic Recall-at-100: 5.00%
2018-05-27 16:27:18,204:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 16:28:03,930:INFO: Rheumatoid Arthritis Recall-at-100: 3.81%
2018-05-27 16:28:03,931:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 16:28:48,262:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-05-27 16:28:48,264:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 16:29:34,087:INFO: Anemia Recall-at-100: 13.33%
2018-05-27 16:29:34,089:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 16:30:19,611:INFO: Cholangiocarcinoma Recall-at-100: 5.00%
2018-05-27 16:30:19,613:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 16:31:06,915:INFO: Neuroendocrine Tumors Recall-at-100: 20.00%
2018-05-27 16:31:06,916:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 16:31:53,907:INFO: Malaria Recall-at-100: 5.00%
2018-05-27 16:31:53,908:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 16:32:41,614:INFO: Hyperhomocysteinemia Recall-at-100: 10.00%
2018-05-27 16:32:41,615:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 16:33:29,466:INFO: HIV Infections Recall-at-100: 13.22%
2018-05-27 16:33:29,467:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 16:34:16,543:INFO: Ankylosing spondylitis Recall-at-100: 20.00%
2018-05-27 16:34:16,543:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 16:35:03,612:INFO: Adenoid Cystic Carcinoma Recall-at-100: 5.00%
2018-05-27 16:35:03,613:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 16:35:49,898:INFO: Juvenile arthritis Recall-at-100: 0.83%
2018-05-27 16:35:49,899:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 16:36:35,955:INFO: Neoplasms, Experimental Recall-at-100: 9.17%
2018-05-27 16:36:35,956:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 16:37:21,862:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 10.00%
2018-05-27 16:37:21,862:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 16:38:01,552:INFO: Alopecia Areata Recall-at-100: 22.22%
2018-05-27 16:38:01,552:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 16:38:47,926:INFO: Alopecia Recall-at-100: 0.00%
2018-05-27 16:38:47,927:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 16:39:32,715:INFO: Bradycardia Recall-at-100: 38.33%
2018-05-27 16:39:32,716:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 16:40:18,007:INFO: Common Variable Immunodeficiency Recall-at-100: 45.00%
2018-05-27 16:40:18,007:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 16:41:03,510:INFO: Glomerulonephritis Recall-at-100: 40.00%
2018-05-27 16:41:03,510:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 16:41:48,283:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 6.67%
2018-05-27 16:41:48,283:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 16:42:35,428:INFO: Lung Injury Recall-at-100: 20.00%
2018-05-27 16:42:35,429:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 16:43:21,987:INFO: Hypercalcemia Recall-at-100: 10.00%
2018-05-27 16:43:21,988:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 16:45:45,307:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 16:45:45,307:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 16:45:45,307:INFO: ======================================
2018-05-27 16:45:45,307:INFO: Loading PPI Network...
2018-05-27 16:45:52,808:INFO: Loading Disease Associations...
2018-05-27 16:46:01,622:INFO: Running Experiment...
2018-05-27 16:46:01,622:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 16:46:01,838:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 16:46:49,790:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 16:46:49,790:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 16:46:49,790:INFO: ======================================
2018-05-27 16:46:49,790:INFO: Loading PPI Network...
2018-05-27 16:46:58,237:INFO: Loading Disease Associations...
2018-05-27 16:47:08,278:INFO: Running Experiment...
2018-05-27 16:47:08,278:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 16:47:08,504:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 16:47:43,453:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-27 16:47:43,454:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 16:48:15,631:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 16:48:15,631:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 16:48:47,652:INFO: Zellweger Syndrome Recall-at-100: 75.00%
2018-05-27 16:48:47,653:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 16:49:19,454:INFO: Psoriasis Recall-at-100: 7.62%
2018-05-27 16:49:19,454:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 16:49:51,221:INFO: Nephrotic Syndrome Recall-at-100: 13.33%
2018-05-27 16:49:51,222:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 16:50:07,932:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 16:50:07,932:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 16:50:07,932:INFO: ======================================
2018-05-27 16:50:07,932:INFO: Loading PPI Network...
2018-05-27 16:50:20,171:INFO: Loading Disease Associations...
2018-05-27 16:50:30,670:INFO: Running Experiment...
2018-05-27 16:50:30,670:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 16:50:30,827:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 16:51:07,328:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 16:51:07,328:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 16:51:07,328:INFO: ======================================
2018-05-27 16:51:07,328:INFO: Loading PPI Network...
2018-05-27 16:51:15,088:INFO: Loading Disease Associations...
2018-05-27 16:51:27,420:INFO: Running Experiment...
2018-05-27 16:51:27,421:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 16:51:27,667:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 16:52:28,700:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 20.00%
2018-05-27 16:52:28,701:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 16:53:25,681:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 16:53:25,682:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 16:54:23,096:INFO: Zellweger Syndrome Recall-at-100: 75.00%
2018-05-27 16:54:23,097:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 16:55:20,188:INFO: Psoriasis Recall-at-100: 10.95%
2018-05-27 16:55:20,189:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 16:56:17,639:INFO: Nephrotic Syndrome Recall-at-100: 8.33%
2018-05-27 16:56:17,640:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 16:57:14,682:INFO: Nephrosis Recall-at-100: 5.00%
2018-05-27 16:57:14,683:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 16:58:12,429:INFO: Mouth Diseases Recall-at-100: 10.00%
2018-05-27 16:58:12,429:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 16:59:10,081:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-27 16:59:10,082:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:00:36,692:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:00:36,693:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:00:36,693:INFO: ======================================
2018-05-27 17:00:36,693:INFO: Loading PPI Network...
2018-05-27 17:00:45,714:INFO: Loading Disease Associations...
2018-05-27 17:00:57,466:INFO: Running Experiment...
2018-05-27 17:00:57,467:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:00:57,686:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 17:01:54,312:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-27 17:01:54,313:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:02:49,048:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:02:49,049:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:03:43,235:INFO: Zellweger Syndrome Recall-at-100: 80.00%
2018-05-27 17:03:43,236:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:04:37,582:INFO: Psoriasis Recall-at-100: 6.19%
2018-05-27 17:04:37,583:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:05:29,838:INFO: Nephrotic Syndrome Recall-at-100: 26.67%
2018-05-27 17:05:29,839:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:06:24,504:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:06:24,505:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:09:51,554:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:09:51,554:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:09:51,554:INFO: ======================================
2018-05-27 17:09:51,554:INFO: Loading PPI Network...
2018-05-27 17:10:00,622:INFO: Loading Disease Associations...
2018-05-27 17:10:09,236:INFO: Running Experiment...
2018-05-27 17:10:09,237:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:10:09,412:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 17:11:45,663:INFO: Disease Protein Prediction in the PPI Network
2018-05-27 17:11:45,664:INFO: Sabri Eyuboglu  -- SNAP Group
2018-05-27 17:11:45,664:INFO: ======================================
2018-05-27 17:11:45,664:INFO: Loading PPI Network...
2018-05-27 17:11:59,005:INFO: Loading Disease Associations...
2018-05-27 17:12:09,624:INFO: Running Experiment...
2018-05-27 17:12:09,624:INFO: Experiment Progress: 0.0% -- 0/519
2018-05-27 17:12:09,865:WARNING: From /dfs/scratch0/sabri/dpp-experiments/source/gcn/metrics.py:6: softmax_cross_entropy_with_logits (from tensorflow.python.ops.nn_ops) is deprecated and will be removed in a future version.
Instructions for updating:

Future major versions of TensorFlow will allow gradients to flow
into the labels input on backprop by default.

See tf.nn.softmax_cross_entropy_with_logits_v2.

2018-05-27 17:12:42,922:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-05-27 17:12:42,923:INFO: Experiment Progress: 0.0% -- 1/519
2018-05-27 17:13:12,458:INFO: Psychoses, Substance-Induced Recall-at-100: 0.00%
2018-05-27 17:13:12,458:INFO: Experiment Progress: 0.0% -- 2/519
2018-05-27 17:13:41,006:INFO: Zellweger Syndrome Recall-at-100: 90.00%
2018-05-27 17:13:41,007:INFO: Experiment Progress: 0.0% -- 3/519
2018-05-27 17:14:10,132:INFO: Psoriasis Recall-at-100: 4.52%
2018-05-27 17:14:10,133:INFO: Experiment Progress: 0.0% -- 4/519
2018-05-27 17:14:38,997:INFO: Nephrotic Syndrome Recall-at-100: 13.33%
2018-05-27 17:14:38,999:INFO: Experiment Progress: 0.0% -- 5/519
2018-05-27 17:15:07,242:INFO: Nephrosis Recall-at-100: 0.00%
2018-05-27 17:15:07,243:INFO: Experiment Progress: 1.0% -- 6/519
2018-05-27 17:15:35,782:INFO: Mouth Diseases Recall-at-100: 20.00%
2018-05-27 17:15:35,783:INFO: Experiment Progress: 1.0% -- 7/519
2018-05-27 17:16:03,760:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-05-27 17:16:03,761:INFO: Experiment Progress: 1.0% -- 8/519
2018-05-27 17:16:32,993:INFO: Substance-Related Disorders Recall-at-100: 2.91%
2018-05-27 17:16:32,994:INFO: Experiment Progress: 1.0% -- 9/519
2018-05-27 17:17:01,386:INFO: Anemia, Hemolytic Recall-at-100: 25.00%
2018-05-27 17:17:01,386:INFO: Experiment Progress: 1.0% -- 10/519
2018-05-27 17:17:30,183:INFO: Rheumatoid Arthritis Recall-at-100: 2.86%
2018-05-27 17:17:30,184:INFO: Experiment Progress: 2.0% -- 11/519
2018-05-27 17:17:57,915:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-05-27 17:17:57,916:INFO: Experiment Progress: 2.0% -- 12/519
2018-05-27 17:18:26,724:INFO: Anemia Recall-at-100: 11.67%
2018-05-27 17:18:26,725:INFO: Experiment Progress: 2.0% -- 13/519
2018-05-27 17:18:55,199:INFO: Cholangiocarcinoma Recall-at-100: 16.67%
2018-05-27 17:18:55,200:INFO: Experiment Progress: 2.0% -- 14/519
2018-05-27 17:19:23,796:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-05-27 17:19:23,798:INFO: Experiment Progress: 2.0% -- 15/519
2018-05-27 17:19:52,739:INFO: Malaria Recall-at-100: 5.00%
2018-05-27 17:19:52,740:INFO: Experiment Progress: 3.0% -- 16/519
2018-05-27 17:20:21,439:INFO: Hyperhomocysteinemia Recall-at-100: 15.00%
2018-05-27 17:20:21,440:INFO: Experiment Progress: 3.0% -- 17/519
2018-05-27 17:20:50,029:INFO: HIV Infections Recall-at-100: 15.11%
2018-05-27 17:20:50,030:INFO: Experiment Progress: 3.0% -- 18/519
2018-05-27 17:21:18,786:INFO: Ankylosing spondylitis Recall-at-100: 10.00%
2018-05-27 17:21:18,787:INFO: Experiment Progress: 3.0% -- 19/519
2018-05-27 17:21:47,732:INFO: Adenoid Cystic Carcinoma Recall-at-100: 6.00%
2018-05-27 17:21:47,732:INFO: Experiment Progress: 3.0% -- 20/519
2018-05-27 17:22:16,051:INFO: Juvenile arthritis Recall-at-100: 2.44%
2018-05-27 17:22:16,052:INFO: Experiment Progress: 4.0% -- 21/519
2018-05-27 17:22:45,032:INFO: Neoplasms, Experimental Recall-at-100: 11.67%
2018-05-27 17:22:45,033:INFO: Experiment Progress: 4.0% -- 22/519
2018-05-27 17:23:14,404:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 10.00%
2018-05-27 17:23:14,405:INFO: Experiment Progress: 4.0% -- 23/519
2018-05-27 17:23:40,621:INFO: Alopecia Areata Recall-at-100: 22.22%
2018-05-27 17:23:40,622:INFO: Experiment Progress: 4.0% -- 24/519
2018-05-27 17:24:09,042:INFO: Alopecia Recall-at-100: 10.00%
2018-05-27 17:24:09,044:INFO: Experiment Progress: 4.0% -- 25/519
2018-05-27 17:24:37,167:INFO: Bradycardia Recall-at-100: 38.33%
2018-05-27 17:24:37,168:INFO: Experiment Progress: 5.0% -- 26/519
2018-05-27 17:25:05,445:INFO: Common Variable Immunodeficiency Recall-at-100: 20.00%
2018-05-27 17:25:05,446:INFO: Experiment Progress: 5.0% -- 27/519
2018-05-27 17:25:34,262:INFO: Glomerulonephritis Recall-at-100: 36.67%
2018-05-27 17:25:34,263:INFO: Experiment Progress: 5.0% -- 28/519
2018-05-27 17:26:03,336:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 6.67%
2018-05-27 17:26:03,337:INFO: Experiment Progress: 5.0% -- 29/519
2018-05-27 17:26:31,859:INFO: Lung Injury Recall-at-100: 25.00%
2018-05-27 17:26:31,860:INFO: Experiment Progress: 5.0% -- 30/519
2018-05-27 17:27:00,484:INFO: Hypercalcemia Recall-at-100: 0.00%
2018-05-27 17:27:00,485:INFO: Experiment Progress: 5.0% -- 31/519
2018-05-27 17:27:29,677:INFO: Cerebrovascular accident Recall-at-100: 16.67%
2018-05-27 17:27:29,678:INFO: Experiment Progress: 6.0% -- 32/519
2018-05-27 17:27:58,947:INFO: Diaphragmatic Hernia Recall-at-100: 15.00%
2018-05-27 17:27:58,948:INFO: Experiment Progress: 6.0% -- 33/519
2018-05-27 17:28:27,998:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-05-27 17:28:27,999:INFO: Experiment Progress: 6.0% -- 34/519
2018-05-27 17:28:56,912:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-05-27 17:28:56,912:INFO: Experiment Progress: 6.0% -- 35/519
2018-05-27 17:29:13,968:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-05-27 17:29:13,969:INFO: Experiment Progress: 6.0% -- 36/519
2018-05-27 17:29:43,370:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-05-27 17:29:43,371:INFO: Experiment Progress: 7.0% -- 37/519
2018-05-27 17:30:12,604:INFO: Pathological accumulation of air in tissues Recall-at-100: 10.00%
2018-05-27 17:30:12,605:INFO: Experiment Progress: 7.0% -- 38/519
2018-05-27 17:30:41,518:INFO: Craniosynostosis Recall-at-100: 10.00%
2018-05-27 17:30:41,519:INFO: Experiment Progress: 7.0% -- 39/519
2018-05-27 17:31:09,932:INFO: Head and Neck Neoplasms Recall-at-100: 0.00%
2018-05-27 17:31:09,934:INFO: Experiment Progress: 7.0% -- 40/519
2018-05-27 17:31:38,782:INFO: Brain Neoplasms Recall-at-100: 13.33%
2018-05-27 17:31:38,783:INFO: Experiment Progress: 7.0% -- 41/519
2018-05-27 17:32:07,946:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-05-27 17:32:07,947:INFO: Experiment Progress: 8.0% -- 42/519
2018-05-27 17:32:36,916:INFO: Chromosome Aberrations Recall-at-100: 5.00%
2018-05-27 17:32:36,916:INFO: Experiment Progress: 8.0% -- 43/519
2018-05-27 17:33:05,205:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 10.00%
2018-05-27 17:33:05,206:INFO: Experiment Progress: 8.0% -- 44/519
2018-05-27 17:33:34,608:INFO: Refractive Errors Recall-at-100: 0.00%
2018-05-27 17:33:34,609:INFO: Experiment Progress: 8.0% -- 45/519
2018-05-27 17:34:02,934:INFO: Hepatitis C Recall-at-100: 5.00%
2018-05-27 17:34:02,935:INFO: Experiment Progress: 8.0% -- 46/519
2018-05-27 17:34:32,084:INFO: Mesothelioma Recall-at-100: 5.00%
2018-05-27 17:34:32,085:INFO: Experiment Progress: 9.0% -- 47/519
2018-05-27 17:34:46,902:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-05-27 17:34:46,903:INFO: Experiment Progress: 9.0% -- 48/519
2018-05-27 17:35:15,316:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-05-27 17:35:15,317:INFO: Experiment Progress: 9.0% -- 49/519
2018-05-27 17:35:44,315:INFO: Kallmann Syndrome Recall-at-100: 10.00%
2018-05-27 17:35:44,315:INFO: Experiment Progress: 9.0% -- 50/519
2018-05-27 17:36:12,189:INFO: Lipoidosis Recall-at-100: 10.00%
2018-05-27 17:36:12,190:INFO: Experiment Progress: 9.0% -- 51/519
2018-05-27 17:36:40,232:INFO: Diabetes Mellitus Recall-at-100: 11.67%
2018-05-27 17:36:40,232:INFO: Experiment Progress: 10.0% -- 52/519
2018-05-27 17:37:09,300:INFO: Fibrosis Recall-at-100: 17.50%
2018-05-27 17:37:09,300:INFO: Experiment Progress: 10.0% -- 53/519
2018-05-27 17:37:37,441:INFO: Hypercholesterolemia Recall-at-100: 20.00%
2018-05-27 17:37:37,441:INFO: Experiment Progress: 10.0% -- 54/519
2018-05-27 17:38:05,777:INFO: Microcephaly Recall-at-100: 10.00%
2018-05-27 17:38:05,778:INFO: Experiment Progress: 10.0% -- 55/519
2018-05-27 17:38:32,074:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-05-27 17:38:32,076:INFO: Experiment Progress: 10.0% -- 56/519
2018-05-27 17:39:00,715:INFO: Common Migraine Recall-at-100: 0.00%
2018-05-27 17:39:00,716:INFO: Experiment Progress: 10.0% -- 57/519
2018-05-27 17:39:29,793:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-05-27 17:39:29,793:INFO: Experiment Progress: 11.0% -- 58/519
2018-05-27 17:39:58,426:INFO: Growth Disorders Recall-at-100: 0.00%
2018-05-27 17:39:58,427:INFO: Experiment Progress: 11.0% -- 59/519
2018-05-27 17:40:24,254:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-05-27 17:40:24,255:INFO: Experiment Progress: 11.0% -- 60/519
2018-05-27 17:40:54,307:INFO: Epilepsy, Temporal Lobe Recall-at-100: 20.00%
2018-05-27 17:40:54,308:INFO: Experiment Progress: 11.0% -- 61/519
2018-05-27 17:41:24,293:INFO: Memory Disorders Recall-at-100: 2.50%
2018-05-27 17:41:24,293:INFO: Experiment Progress: 11.0% -- 62/519
2018-05-27 17:41:52,872:INFO: Catalepsy Recall-at-100: 35.00%
2018-05-27 17:41:52,873:INFO: Experiment Progress: 12.0% -- 63/519
2018-05-27 17:42:21,988:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 30.00%
2018-05-27 17:42:21,989:INFO: Experiment Progress: 12.0% -- 64/519
2018-05-27 17:42:51,638:INFO: Acute Promyelocytic Leukemia Recall-at-100: 11.67%
2018-05-27 17:42:51,638:INFO: Experiment Progress: 12.0% -- 65/519
2018-05-27 17:43:21,646:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-05-27 17:43:21,647:INFO: Experiment Progress: 12.0% -- 66/519
2018-05-27 17:43:51,181:INFO: Gout Recall-at-100: 0.00%
2018-05-27 17:43:51,182:INFO: Experiment Progress: 12.0% -- 67/519
2018-05-27 17:44:19,804:INFO: Coronary Artery Disease Recall-at-100: 0.00%
2018-05-27 17:44:19,805:INFO: Experiment Progress: 13.0% -- 68/519
2018-05-27 17:44:47,875:INFO: Venous Thromboembolism Recall-at-100: 26.67%
2018-05-27 17:44:47,876:INFO: Experiment Progress: 13.0% -- 69/519
2018-05-27 17:45:17,363:INFO: Precancerous Conditions Recall-at-100: 5.95%
2018-05-27 17:45:17,364:INFO: Experiment Progress: 13.0% -- 70/519
2018-05-27 17:45:46,598:INFO: Crohn Disease Recall-at-100: 4.72%
2018-05-27 17:45:46,600:INFO: Experiment Progress: 13.0% -- 71/519
2018-05-27 17:46:16,343:INFO: Uterine Cervical Neoplasm Recall-at-100: 10.00%
2018-05-27 17:46:16,343:INFO: Experiment Progress: 13.0% -- 72/519
2018-05-27 17:46:45,568:INFO: Dyskinesia, Drug-Induced Recall-at-100: 20.00%
2018-05-27 17:46:45,569:INFO: Experiment Progress: 14.0% -- 73/519
2018-05-27 17:47:15,836:INFO: Ataxia, Spinocerebellar Recall-at-100: 0.00%
2018-05-27 17:47:15,836:INFO: Experiment Progress: 14.0% -- 74/519
2018-05-27 17:47:44,650:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 70.00%
2018-05-27 17:47:44,652:INFO: Experiment Progress: 14.0% -- 75/519
2018-05-27 17:48:14,571:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 10.00%
2018-05-27 17:48:14,572:INFO: Experiment Progress: 14.0% -- 76/519
2018-05-27 17:48:43,293:INFO: Acute Lung Injury Recall-at-100: 5.00%
2018-05-27 17:48:43,294:INFO: Experiment Progress: 14.0% -- 77/519
2018-05-27 17:49:12,315:INFO: Liver Cirrhosis, Experimental Recall-at-100: 8.18%
2018-05-27 17:49:12,316:INFO: Experiment Progress: 15.0% -- 78/519
2018-05-27 17:49:41,145:INFO: Chloracne Recall-at-100: 6.67%
2018-05-27 17:49:41,146:INFO: Experiment Progress: 15.0% -- 79/519
2018-05-27 17:50:10,584:INFO: Liver diseases Recall-at-100: 4.76%
2018-05-27 17:50:10,584:INFO: Experiment Progress: 15.0% -- 80/519
2018-05-27 17:50:39,545:INFO: Kidney Failure, Chronic Recall-at-100: 7.00%
2018-05-27 17:50:39,546:INFO: Experiment Progress: 15.0% -- 81/519
2018-05-27 17:51:09,619:INFO: Weight decreased Recall-at-100: 5.00%
2018-05-27 17:51:09,620:INFO: Experiment Progress: 15.0% -- 82/519
2018-05-27 17:51:39,564:INFO: Leigh Disease Recall-at-100: 55.83%
2018-05-27 17:51:39,566:INFO: Experiment Progress: 15.0% -- 83/519
2018-05-27 17:52:08,898:INFO: Celiac Disease Recall-at-100: 10.00%
2018-05-27 17:52:08,898:INFO: Experiment Progress: 16.0% -- 84/519
2018-05-27 17:52:37,509:INFO: Glaucoma Recall-at-100: 0.00%
2018-05-27 17:52:37,511:INFO: Experiment Progress: 16.0% -- 85/519
2018-05-27 17:53:06,502:INFO: Tachycardia Recall-at-100: 15.00%
2018-05-27 17:53:06,503:INFO: Experiment Progress: 16.0% -- 86/519
2018-05-27 17:53:36,389:INFO: Breast Cancer, Familial Recall-at-100: 50.00%
2018-05-27 17:53:36,390:INFO: Experiment Progress: 16.0% -- 87/519
2018-05-27 17:54:05,054:INFO: Ischemia Recall-at-100: 0.00%
2018-05-27 17:54:05,055:INFO: Experiment Progress: 16.0% -- 88/519
2018-05-27 17:54:30,914:INFO: Adenomatous Polyposis Coli Recall-at-100: 11.11%
2018-05-27 17:54:30,915:INFO: Experiment Progress: 17.0% -- 89/519
2018-05-27 17:54:59,841:INFO: Thyroid Diseases Recall-at-100: 10.00%
2018-05-27 17:54:59,842:INFO: Experiment Progress: 17.0% -- 90/519
2018-05-27 17:55:21,997:INFO: Panic Disorder Recall-at-100: 0.00%
2018-05-27 17:55:22,000:INFO: Experiment Progress: 17.0% -- 91/519
2018-05-27 17:55:50,348:INFO: Colorectal Neoplasms Recall-at-100: 1.90%
2018-05-27 17:55:50,349:INFO: Experiment Progress: 17.0% -- 92/519
2018-05-27 17:56:18,377:INFO: Adrenal Gland Neoplasms Recall-at-100: 40.00%
2018-05-27 17:56:18,378:INFO: Experiment Progress: 17.0% -- 93/519
2018-05-27 17:56:47,302:INFO: Sudden infant death syndrome Recall-at-100: 10.00%
2018-05-27 17:56:47,303:INFO: Experiment Progress: 18.0% -- 94/519
2018-05-27 17:57:16,019:INFO: Neuroblastoma Recall-at-100: 8.50%
2018-05-27 17:57:16,020:INFO: Experiment Progress: 18.0% -- 95/519
2018-05-27 17:57:45,062:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-05-27 17:57:45,064:INFO: Experiment Progress: 18.0% -- 96/519
2018-05-27 17:58:13,769:INFO: Animal Mammary Neoplasms Recall-at-100: 7.25%
2018-05-27 17:58:13,770:INFO: Experiment Progress: 18.0% -- 97/519
2018-05-27 17:58:42,391:INFO: Osteochondrodysplasias Recall-at-100: 25.00%
2018-05-27 17:58:42,391:INFO: Experiment Progress: 18.0% -- 98/519
2018-05-27 17:59:11,148:INFO: Hepatolenticular Degeneration Recall-at-100: 8.33%
2018-05-27 17:59:11,148:INFO: Experiment Progress: 19.0% -- 99/519
2018-05-27 17:59:38,451:INFO: Fanconi Anemia Recall-at-100: 70.00%
2018-05-27 17:59:38,452:INFO: Experiment Progress: 19.0% -- 100/519
2018-05-27 18:00:06,483:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-05-27 18:00:06,484:INFO: Experiment Progress: 19.0% -- 101/519
2018-05-27 18:00:35,136:INFO: Limb Deformities, Congenital Recall-at-100: 15.00%
2018-05-27 18:00:35,137:INFO: Experiment Progress: 19.0% -- 102/519
2018-05-27 18:01:00,907:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-05-27 18:01:00,907:INFO: Experiment Progress: 19.0% -- 103/519
2018-05-27 18:01:28,840:INFO: Mammary Neoplasms, Experimental Recall-at-100: 3.96%
2018-05-27 18:01:28,840:INFO: Experiment Progress: 20.0% -- 104/519
2018-05-27 18:01:57,257:INFO: Heart valve disease Recall-at-100: 3.33%
2018-05-27 18:01:57,258:INFO: Experiment Progress: 20.0% -- 105/519
2018-05-27 18:02:25,216:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 11.67%
2018-05-27 18:02:25,217:INFO: Experiment Progress: 20.0% -- 106/519
2018-05-27 18:02:53,816:INFO: Hepatitis Recall-at-100: 5.00%
2018-05-27 18:02:53,817:INFO: Experiment Progress: 20.0% -- 107/519
2018-05-27 18:03:22,220:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-05-27 18:03:22,220:INFO: Experiment Progress: 20.0% -- 108/519
2018-05-27 18:03:50,389:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 25.00%
2018-05-27 18:03:50,390:INFO: Experiment Progress: 21.0% -- 109/519
2018-05-27 18:04:19,380:INFO: Colon Carcinoma Recall-at-100: 13.33%
2018-05-27 18:04:19,381:INFO: Experiment Progress: 21.0% -- 110/519
2018-05-27 18:04:47,962:INFO: Hepatic Encephalopathy Recall-at-100: 30.00%
2018-05-27 18:04:47,963:INFO: Experiment Progress: 21.0% -- 111/519
2018-05-27 18:05:16,443:INFO: Multiple Sclerosis Recall-at-100: 1.11%
2018-05-27 18:05:16,445:INFO: Experiment Progress: 21.0% -- 112/519
2018-05-27 18:05:44,888:INFO: Neurogenic Inflammation Recall-at-100: 0.00%
2018-05-27 18:05:44,889:INFO: Experiment Progress: 21.0% -- 113/519
2018-05-27 18:06:13,589:INFO: Lupus Erythematosus, Systemic Recall-at-100: 5.18%
2018-05-27 18:06:13,590:INFO: Experiment Progress: 21.0% -- 114/519
2018-05-27 18:06:43,242:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 20.00%
2018-05-27 18:06:43,243:INFO: Experiment Progress: 22.0% -- 115/519
2018-05-27 18:07:11,608:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 9.00%
2018-05-27 18:07:11,608:INFO: Experiment Progress: 22.0% -- 116/519
2018-05-27 18:07:39,973:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 3.33%
2018-05-27 18:07:39,974:INFO: Experiment Progress: 22.0% -- 117/519
2018-05-27 18:08:09,039:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-05-27 18:08:09,039:INFO: Experiment Progress: 22.0% -- 118/519
2018-05-27 18:08:37,325:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-05-27 18:08:37,326:INFO: Experiment Progress: 22.0% -- 119/519
2018-05-27 18:09:05,767:INFO: Hepatitis, Autoimmune Recall-at-100: 30.00%
2018-05-27 18:09:05,768:INFO: Experiment Progress: 23.0% -- 120/519
2018-05-27 18:09:35,130:INFO: Prostatic Neoplasms Recall-at-100: 5.76%
2018-05-27 18:09:35,130:INFO: Experiment Progress: 23.0% -- 121/519
2018-05-27 18:10:03,628:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 80.00%
2018-05-27 18:10:03,628:INFO: Experiment Progress: 23.0% -- 122/519
2018-05-27 18:10:31,409:INFO: Hypospadias Recall-at-100: 0.00%
2018-05-27 18:10:31,409:INFO: Experiment Progress: 23.0% -- 123/519
2018-05-27 18:11:00,582:INFO: Multiple Myeloma Recall-at-100: 8.33%
2018-05-27 18:11:00,583:INFO: Experiment Progress: 23.0% -- 124/519
2018-05-27 18:11:29,351:INFO: Fatty Liver Recall-at-100: 16.00%
2018-05-27 18:11:29,352:INFO: Experiment Progress: 24.0% -- 125/519
2018-05-27 18:11:58,382:INFO: Leishmaniasis, Visceral Recall-at-100: 40.00%
2018-05-27 18:11:58,383:INFO: Experiment Progress: 24.0% -- 126/519
2018-05-27 18:12:25,824:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 10.00%
2018-05-27 18:12:25,824:INFO: Experiment Progress: 24.0% -- 127/519
2018-05-27 18:12:54,339:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-05-27 18:12:54,340:INFO: Experiment Progress: 24.0% -- 128/519
2018-05-27 18:13:22,229:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 25.00%
2018-05-27 18:13:22,230:INFO: Experiment Progress: 24.0% -- 129/519
2018-05-27 18:13:50,995:INFO: Bipolar Disorder Recall-at-100: 3.33%
2018-05-27 18:13:50,995:INFO: Experiment Progress: 25.0% -- 130/519
2018-05-27 18:14:20,190:INFO: Erectile dysfunction Recall-at-100: 30.00%
2018-05-27 18:14:20,190:INFO: Experiment Progress: 25.0% -- 131/519
2018-05-27 18:14:49,549:INFO: Meckel-Gruber syndrome Recall-at-100: 70.00%
2018-05-27 18:14:49,550:INFO: Experiment Progress: 25.0% -- 132/519
2018-05-27 18:15:18,060:INFO: Colonic Neoplasms Recall-at-100: 5.45%
2018-05-27 18:15:18,061:INFO: Experiment Progress: 25.0% -- 133/519
2018-05-27 18:15:47,218:INFO: Autistic Disorder Recall-at-100: 4.67%
2018-05-27 18:15:47,218:INFO: Experiment Progress: 25.0% -- 134/519
2018-05-27 18:16:17,279:INFO: Liver Neoplasms, Experimental Recall-at-100: 5.67%
2018-05-27 18:16:17,280:INFO: Experiment Progress: 26.0% -- 135/519
2018-05-27 18:16:45,130:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 0.00%
2018-05-27 18:16:45,130:INFO: Experiment Progress: 26.0% -- 136/519
2018-05-27 18:17:13,170:INFO: Narcolepsy Recall-at-100: 0.00%
2018-05-27 18:17:13,171:INFO: Experiment Progress: 26.0% -- 137/519
2018-05-27 18:17:41,992:INFO: Fever Recall-at-100: 15.00%
2018-05-27 18:17:41,992:INFO: Experiment Progress: 26.0% -- 138/519
2018-05-27 18:18:09,617:INFO: Adenocarcinoma Recall-at-100: 13.18%
2018-05-27 18:18:09,618:INFO: Experiment Progress: 26.0% -- 139/519
2018-05-27 18:18:38,283:INFO: Aortic Valve Insufficiency Recall-at-100: 35.00%
2018-05-27 18:18:38,283:INFO: Experiment Progress: 26.0% -- 140/519
2018-05-27 18:19:06,822:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 15.00%
2018-05-27 18:19:06,822:INFO: Experiment Progress: 27.0% -- 141/519
2018-05-27 18:19:34,516:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 13.33%
2018-05-27 18:19:34,517:INFO: Experiment Progress: 27.0% -- 142/519
2018-05-27 18:20:02,760:INFO: Hypertensive disease Recall-at-100: 8.98%
2018-05-27 18:20:02,761:INFO: Experiment Progress: 27.0% -- 143/519
2018-05-27 18:20:32,206:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 30.00%
2018-05-27 18:20:32,207:INFO: Experiment Progress: 27.0% -- 144/519
2018-05-27 18:21:02,190:INFO: Leprosy Recall-at-100: 0.00%
2018-05-27 18:21:02,192:INFO: Experiment Progress: 27.0% -- 145/519
2018-05-27 18:21:30,722:INFO: Myocardial Infarction Recall-at-100: 8.19%
2018-05-27 18:21:30,723:INFO: Experiment Progress: 28.0% -- 146/519
2018-05-27 18:21:59,829:INFO: Urticaria Recall-at-100: 5.00%
2018-05-27 18:21:59,830:INFO: Experiment Progress: 28.0% -- 147/519
2018-05-27 18:22:27,830:INFO: Cardiac Arrhythmia Recall-at-100: 5.00%
2018-05-27 18:22:27,831:INFO: Experiment Progress: 28.0% -- 148/519
2018-05-27 18:22:56,966:INFO: Hemochromatosis Recall-at-100: 15.00%
2018-05-27 18:22:56,967:INFO: Experiment Progress: 28.0% -- 149/519
2018-05-27 18:23:26,758:INFO: Pancreatic Neoplasm Recall-at-100: 7.50%
2018-05-27 18:23:26,759:INFO: Experiment Progress: 28.0% -- 150/519
2018-05-27 18:23:55,279:INFO: Cardiomyopathy, Dilated Recall-at-100: 22.00%
2018-05-27 18:23:55,280:INFO: Experiment Progress: 29.0% -- 151/519
2018-05-27 18:24:23,925:INFO: Papilloma Recall-at-100: 20.00%
2018-05-27 18:24:23,926:INFO: Experiment Progress: 29.0% -- 152/519
2018-05-27 18:24:51,935:INFO: Pain Recall-at-100: 9.00%
2018-05-27 18:24:51,936:INFO: Experiment Progress: 29.0% -- 153/519
2018-05-27 18:25:20,121:INFO: Congenital Abnormality Recall-at-100: 0.00%
2018-05-27 18:25:20,122:INFO: Experiment Progress: 29.0% -- 154/519
2018-05-27 18:25:48,987:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 50.00%
2018-05-27 18:25:48,988:INFO: Experiment Progress: 29.0% -- 155/519
2018-05-27 18:26:17,906:INFO: Kidney Diseases Recall-at-100: 2.50%
2018-05-27 18:26:17,906:INFO: Experiment Progress: 30.0% -- 156/519
2018-05-27 18:26:46,712:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-05-27 18:26:46,713:INFO: Experiment Progress: 30.0% -- 157/519
2018-05-27 18:27:15,582:INFO: Basal cell carcinoma Recall-at-100: 8.33%
2018-05-27 18:27:15,583:INFO: Experiment Progress: 30.0% -- 158/519
2018-05-27 18:27:43,976:INFO: Liver carcinoma Recall-at-100: 9.63%
2018-05-27 18:27:43,976:INFO: Experiment Progress: 30.0% -- 159/519
2018-05-27 18:28:12,723:INFO: gliosarcoma Recall-at-100: 5.00%
2018-05-27 18:28:12,724:INFO: Experiment Progress: 30.0% -- 160/519
2018-05-27 18:28:41,261:INFO: Acute Coronary Syndrome Recall-at-100: 16.67%
2018-05-27 18:28:41,262:INFO: Experiment Progress: 31.0% -- 161/519
2018-05-27 18:29:09,500:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-05-27 18:29:09,501:INFO: Experiment Progress: 31.0% -- 162/519
2018-05-27 18:29:38,445:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-05-27 18:29:38,446:INFO: Experiment Progress: 31.0% -- 163/519
2018-05-27 18:30:06,977:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-05-27 18:30:06,978:INFO: Experiment Progress: 31.0% -- 164/519
2018-05-27 18:30:36,494:INFO: Schizophrenia Recall-at-100: 2.10%
2018-05-27 18:30:36,494:INFO: Experiment Progress: 31.0% -- 165/519
2018-05-27 18:31:05,639:INFO: Atrophic Recall-at-100: 10.00%
2018-05-27 18:31:05,639:INFO: Experiment Progress: 31.0% -- 166/519
2018-05-27 18:31:34,664:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 0.00%
2018-05-27 18:31:34,665:INFO: Experiment Progress: 32.0% -- 167/519
2018-05-27 18:32:03,974:INFO: Lobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:32:03,975:INFO: Experiment Progress: 32.0% -- 168/519
2018-05-27 18:32:33,884:INFO: Alobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:32:33,885:INFO: Experiment Progress: 32.0% -- 169/519
2018-05-27 18:33:03,105:INFO: Immunologic Deficiency Syndromes Recall-at-100: 25.00%
2018-05-27 18:33:03,106:INFO: Experiment Progress: 32.0% -- 170/519
2018-05-27 18:33:33,414:INFO: Ataxia Recall-at-100: 20.00%
2018-05-27 18:33:33,415:INFO: Experiment Progress: 32.0% -- 171/519
2018-05-27 18:34:02,874:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 0.00%
2018-05-27 18:34:02,875:INFO: Experiment Progress: 33.0% -- 172/519
2018-05-27 18:34:31,895:INFO: Retinitis Pigmentosa Recall-at-100: 5.71%
2018-05-27 18:34:31,896:INFO: Experiment Progress: 33.0% -- 173/519
2018-05-27 18:35:00,720:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 8.61%
2018-05-27 18:35:00,720:INFO: Experiment Progress: 33.0% -- 174/519
2018-05-27 18:35:29,472:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-05-27 18:35:29,472:INFO: Experiment Progress: 33.0% -- 175/519
2018-05-27 18:35:58,793:INFO: Diarrhea Recall-at-100: 0.00%
2018-05-27 18:35:58,793:INFO: Experiment Progress: 33.0% -- 176/519
2018-05-27 18:36:28,779:INFO: Myocardial Ischemia Recall-at-100: 3.01%
2018-05-27 18:36:28,779:INFO: Experiment Progress: 34.0% -- 177/519
2018-05-27 18:36:57,911:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-05-27 18:36:57,913:INFO: Experiment Progress: 34.0% -- 178/519
2018-05-27 18:37:24,380:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-05-27 18:37:24,381:INFO: Experiment Progress: 34.0% -- 179/519
2018-05-27 18:37:54,443:INFO: Myopathy Recall-at-100: 3.33%
2018-05-27 18:37:54,445:INFO: Experiment Progress: 34.0% -- 180/519
2018-05-27 18:38:23,884:INFO: Adverse reaction to drug Recall-at-100: 5.67%
2018-05-27 18:38:23,885:INFO: Experiment Progress: 34.0% -- 181/519
2018-05-27 18:38:52,663:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 10.00%
2018-05-27 18:38:52,664:INFO: Experiment Progress: 35.0% -- 182/519
2018-05-27 18:39:22,960:INFO: Muscular Atrophy Recall-at-100: 15.00%
2018-05-27 18:39:22,961:INFO: Experiment Progress: 35.0% -- 183/519
2018-05-27 18:39:51,937:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-05-27 18:39:51,939:INFO: Experiment Progress: 35.0% -- 184/519
2018-05-27 18:40:20,958:INFO: Hepatitis B Recall-at-100: 25.00%
2018-05-27 18:40:20,960:INFO: Experiment Progress: 35.0% -- 185/519
2018-05-27 18:40:50,196:INFO: Lung diseases Recall-at-100: 4.50%
2018-05-27 18:40:50,197:INFO: Experiment Progress: 35.0% -- 186/519
2018-05-27 18:41:19,264:INFO: Chronic Obstructive Airway Disease Recall-at-100: 9.00%
2018-05-27 18:41:19,265:INFO: Experiment Progress: 36.0% -- 187/519
2018-05-27 18:41:47,735:INFO: Peripheral Neuropathy Recall-at-100: 3.58%
2018-05-27 18:41:47,736:INFO: Experiment Progress: 36.0% -- 188/519
2018-05-27 18:42:16,747:INFO: Weight Gain Recall-at-100: 3.47%
2018-05-27 18:42:16,748:INFO: Experiment Progress: 36.0% -- 189/519
2018-05-27 18:42:45,481:INFO: Deafness Recall-at-100: 0.00%
2018-05-27 18:42:45,482:INFO: Experiment Progress: 36.0% -- 190/519
2018-05-27 18:43:14,800:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 60.00%
2018-05-27 18:43:14,801:INFO: Experiment Progress: 36.0% -- 191/519
2018-05-27 18:43:43,594:INFO: Attention deficit hyperactivity disorder Recall-at-100: 9.17%
2018-05-27 18:43:43,594:INFO: Experiment Progress: 36.0% -- 192/519
2018-05-27 18:44:13,532:INFO: Tetralogy of Fallot Recall-at-100: 40.00%
2018-05-27 18:44:13,533:INFO: Experiment Progress: 37.0% -- 193/519
2018-05-27 18:44:41,985:INFO: Neurodegenerative Disorders Recall-at-100: 10.83%
2018-05-27 18:44:41,986:INFO: Experiment Progress: 37.0% -- 194/519
2018-05-27 18:45:10,269:INFO: Barrett Esophagus Recall-at-100: 10.00%
2018-05-27 18:45:10,270:INFO: Experiment Progress: 37.0% -- 195/519
2018-05-27 18:45:39,772:INFO: Craniofacial Abnormalities Recall-at-100: 9.00%
2018-05-27 18:45:39,773:INFO: Experiment Progress: 37.0% -- 196/519
2018-05-27 18:46:08,770:INFO: Necrotizing Enterocolitis Recall-at-100: 20.00%
2018-05-27 18:46:08,771:INFO: Experiment Progress: 37.0% -- 197/519
2018-05-27 18:46:38,204:INFO: Hyperlipidemia Recall-at-100: 25.00%
2018-05-27 18:46:38,204:INFO: Experiment Progress: 38.0% -- 198/519
2018-05-27 18:47:08,450:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-05-27 18:47:08,451:INFO: Experiment Progress: 38.0% -- 199/519
2018-05-27 18:47:37,849:INFO: Anoxia Recall-at-100: 5.83%
2018-05-27 18:47:37,850:INFO: Experiment Progress: 38.0% -- 200/519
2018-05-27 18:48:07,327:INFO: Small cell carcinoma of lung Recall-at-100: 12.50%
2018-05-27 18:48:07,328:INFO: Experiment Progress: 38.0% -- 201/519
2018-05-27 18:48:36,305:INFO: Epilepsy Recall-at-100: 9.52%
2018-05-27 18:48:36,306:INFO: Experiment Progress: 38.0% -- 202/519
2018-05-27 18:49:05,204:INFO: Liver Failure, Acute Recall-at-100: 21.67%
2018-05-27 18:49:05,206:INFO: Experiment Progress: 39.0% -- 203/519
2018-05-27 18:49:34,039:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 10.00%
2018-05-27 18:49:34,040:INFO: Experiment Progress: 39.0% -- 204/519
2018-05-27 18:50:03,162:INFO: Cognition Disorders Recall-at-100: 0.00%
2018-05-27 18:50:03,163:INFO: Experiment Progress: 39.0% -- 205/519
2018-05-27 18:50:31,508:INFO: Tonic-Clonic Epilepsy Recall-at-100: 30.00%
2018-05-27 18:50:31,509:INFO: Experiment Progress: 39.0% -- 206/519
2018-05-27 18:51:00,673:INFO: Heart Diseases Recall-at-100: 7.00%
2018-05-27 18:51:00,674:INFO: Experiment Progress: 39.0% -- 207/519
2018-05-27 18:51:30,554:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 10.00%
2018-05-27 18:51:30,555:INFO: Experiment Progress: 40.0% -- 208/519
2018-05-27 18:51:59,607:INFO: Primary biliary cirrhosis Recall-at-100: 20.00%
2018-05-27 18:51:59,608:INFO: Experiment Progress: 40.0% -- 209/519
2018-05-27 18:52:28,933:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-05-27 18:52:28,933:INFO: Experiment Progress: 40.0% -- 210/519
2018-05-27 18:52:58,112:INFO: Marijuana Abuse Recall-at-100: 20.00%
2018-05-27 18:52:58,113:INFO: Experiment Progress: 40.0% -- 211/519
2018-05-27 18:53:27,077:INFO: Long QT Syndrome Recall-at-100: 45.00%
2018-05-27 18:53:27,077:INFO: Experiment Progress: 40.0% -- 212/519
2018-05-27 18:53:57,301:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-05-27 18:53:57,302:INFO: Experiment Progress: 41.0% -- 213/519
2018-05-27 18:54:26,452:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 20.00%
2018-05-27 18:54:26,453:INFO: Experiment Progress: 41.0% -- 214/519
2018-05-27 18:54:55,272:INFO: Insulin Resistance Recall-at-100: 10.00%
2018-05-27 18:54:55,273:INFO: Experiment Progress: 41.0% -- 215/519
2018-05-27 18:55:23,161:INFO: Left Ventricular Hypertrophy Recall-at-100: 23.33%
2018-05-27 18:55:23,161:INFO: Experiment Progress: 41.0% -- 216/519
2018-05-27 18:55:53,264:INFO: Bronchial Hyperreactivity Recall-at-100: 0.00%
2018-05-27 18:55:53,265:INFO: Experiment Progress: 41.0% -- 217/519
2018-05-27 18:56:22,843:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 6.50%
2018-05-27 18:56:22,844:INFO: Experiment Progress: 42.0% -- 218/519
2018-05-27 18:56:51,072:INFO: Fetal Growth Retardation Recall-at-100: 0.00%
2018-05-27 18:56:51,073:INFO: Experiment Progress: 42.0% -- 219/519
2018-05-27 18:57:14,593:INFO: Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 18:57:14,595:INFO: Experiment Progress: 42.0% -- 220/519
2018-05-27 18:57:43,167:INFO: Arthritis, Experimental Recall-at-100: 12.50%
2018-05-27 18:57:43,168:INFO: Experiment Progress: 42.0% -- 221/519
2018-05-27 18:58:12,140:INFO: Congenital Heart Defects Recall-at-100: 5.83%
2018-05-27 18:58:12,142:INFO: Experiment Progress: 42.0% -- 222/519
2018-05-27 18:58:38,841:INFO: Pseudohypoaldosteronism Recall-at-100: 44.44%
2018-05-27 18:58:38,842:INFO: Experiment Progress: 42.0% -- 223/519
2018-05-27 18:59:08,645:INFO: Cataract Recall-at-100: 21.67%
2018-05-27 18:59:08,646:INFO: Experiment Progress: 43.0% -- 224/519
2018-05-27 18:59:38,137:INFO: Giant Cell Glioblastoma Recall-at-100: 25.00%
2018-05-27 18:59:38,138:INFO: Experiment Progress: 43.0% -- 225/519
2018-05-27 19:00:07,882:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-05-27 19:00:07,883:INFO: Experiment Progress: 43.0% -- 226/519
2018-05-27 19:00:36,646:INFO: Body Weight Recall-at-100: 0.00%
2018-05-27 19:00:36,647:INFO: Experiment Progress: 43.0% -- 227/519
2018-05-27 19:01:05,767:INFO: Huntington Disease Recall-at-100: 0.00%
2018-05-27 19:01:05,768:INFO: Experiment Progress: 43.0% -- 228/519
2018-05-27 19:01:34,910:INFO: Glioblastoma Recall-at-100: 8.33%
2018-05-27 19:01:34,911:INFO: Experiment Progress: 44.0% -- 229/519
2018-05-27 19:02:04,114:INFO: Congenital diaphragmatic hernia Recall-at-100: 35.00%
2018-05-27 19:02:04,115:INFO: Experiment Progress: 44.0% -- 230/519
2018-05-27 19:02:32,615:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-05-27 19:02:32,615:INFO: Experiment Progress: 44.0% -- 231/519
2018-05-27 19:03:01,713:INFO: Acute kidney injury Recall-at-100: 7.38%
2018-05-27 19:03:01,713:INFO: Experiment Progress: 44.0% -- 232/519
2018-05-27 19:03:30,555:INFO: Copper-Overload Cirrhosis Recall-at-100: 0.00%
2018-05-27 19:03:30,557:INFO: Experiment Progress: 44.0% -- 233/519
2018-05-27 19:03:59,736:INFO: Spontaneous abortion Recall-at-100: 8.64%
2018-05-27 19:03:59,737:INFO: Experiment Progress: 45.0% -- 234/519
2018-05-27 19:04:29,105:INFO: Glioma Recall-at-100: 9.05%
2018-05-27 19:04:29,106:INFO: Experiment Progress: 45.0% -- 235/519
2018-05-27 19:04:58,653:INFO: Gliosis Recall-at-100: 50.00%
2018-05-27 19:04:58,655:INFO: Experiment Progress: 45.0% -- 236/519
2018-05-27 19:05:27,479:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 80.00%
2018-05-27 19:05:27,480:INFO: Experiment Progress: 45.0% -- 237/519
2018-05-27 19:05:56,782:INFO: Dementia Recall-at-100: 0.00%
2018-05-27 19:05:56,782:INFO: Experiment Progress: 45.0% -- 238/519
2018-05-27 19:06:25,375:INFO: Pancreatitis Recall-at-100: 0.00%
2018-05-27 19:06:25,376:INFO: Experiment Progress: 46.0% -- 239/519
2018-05-27 19:06:54,244:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-05-27 19:06:54,246:INFO: Experiment Progress: 46.0% -- 240/519
2018-05-27 19:07:24,427:INFO: Thyroid Neoplasm Recall-at-100: 12.50%
2018-05-27 19:07:24,428:INFO: Experiment Progress: 46.0% -- 241/519
2018-05-27 19:07:52,974:INFO: Neoplasm Invasiveness Recall-at-100: 14.42%
2018-05-27 19:07:52,974:INFO: Experiment Progress: 46.0% -- 242/519
2018-05-27 19:08:22,380:INFO: Neoplasm Metastasis Recall-at-100: 10.82%
2018-05-27 19:08:22,381:INFO: Experiment Progress: 46.0% -- 243/519
2018-05-27 19:08:51,427:INFO: Albuminuria Recall-at-100: 15.00%
2018-05-27 19:08:51,428:INFO: Experiment Progress: 47.0% -- 244/519
2018-05-27 19:09:20,748:INFO: Pre-Eclampsia Recall-at-100: 5.00%
2018-05-27 19:09:20,749:INFO: Experiment Progress: 47.0% -- 245/519
2018-05-27 19:09:49,756:INFO: Nerve Degeneration Recall-at-100: 12.14%
2018-05-27 19:09:49,757:INFO: Experiment Progress: 47.0% -- 246/519
2018-05-27 19:10:18,882:INFO: Thromboembolism Recall-at-100: 60.00%
2018-05-27 19:10:18,883:INFO: Experiment Progress: 47.0% -- 247/519
2018-05-27 19:10:47,409:INFO: Polycystic Ovary Syndrome Recall-at-100: 2.05%
2018-05-27 19:10:47,410:INFO: Experiment Progress: 47.0% -- 248/519
2018-05-27 19:11:17,544:INFO: Transient Ischemic Attack Recall-at-100: 30.00%
2018-05-27 19:11:17,544:INFO: Experiment Progress: 47.0% -- 249/519
2018-05-27 19:11:46,897:INFO: Brain Ischemia Recall-at-100: 20.00%
2018-05-27 19:11:46,898:INFO: Experiment Progress: 48.0% -- 250/519
2018-05-27 19:12:15,799:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-05-27 19:12:15,800:INFO: Experiment Progress: 48.0% -- 251/519
2018-05-27 19:12:44,705:INFO: Malignant neoplasm of esophagus Recall-at-100: 20.00%
2018-05-27 19:12:44,707:INFO: Experiment Progress: 48.0% -- 252/519
2018-05-27 19:13:13,476:INFO: Degenerative polyarthritis Recall-at-100: 5.44%
2018-05-27 19:13:13,476:INFO: Experiment Progress: 48.0% -- 253/519
2018-05-27 19:13:36,340:INFO: Osteitis Deformans Recall-at-100: 12.50%
2018-05-27 19:13:36,341:INFO: Experiment Progress: 48.0% -- 254/519
2018-05-27 19:14:04,833:INFO: Diabetic Cardiomyopathies Recall-at-100: 10.00%
2018-05-27 19:14:04,835:INFO: Experiment Progress: 49.0% -- 255/519
2018-05-27 19:14:33,562:INFO: Nuclear cataract Recall-at-100: 35.00%
2018-05-27 19:14:33,563:INFO: Experiment Progress: 49.0% -- 256/519
2018-05-27 19:15:02,766:INFO: Anorexia Recall-at-100: 45.00%
2018-05-27 19:15:02,767:INFO: Experiment Progress: 49.0% -- 257/519
2018-05-27 19:15:32,012:INFO: Cocaine-Related Disorders Recall-at-100: 15.28%
2018-05-27 19:15:32,013:INFO: Experiment Progress: 49.0% -- 258/519
2018-05-27 19:16:02,160:INFO: MELAS Syndrome Recall-at-100: 80.00%
2018-05-27 19:16:02,161:INFO: Experiment Progress: 49.0% -- 259/519
2018-05-27 19:16:19,597:INFO: Mitochondrial Myopathies Recall-at-100: 16.67%
2018-05-27 19:16:19,598:INFO: Experiment Progress: 50.0% -- 260/519
2018-05-27 19:16:48,725:INFO: Amphetamine-Related Disorders Recall-at-100: 6.61%
2018-05-27 19:16:48,728:INFO: Experiment Progress: 50.0% -- 261/519
2018-05-27 19:17:17,530:INFO: Birth Weight Recall-at-100: 0.00%
2018-05-27 19:17:17,531:INFO: Experiment Progress: 50.0% -- 262/519
2018-05-27 19:17:46,689:INFO: Brain Diseases Recall-at-100: 5.00%
2018-05-27 19:17:46,690:INFO: Experiment Progress: 50.0% -- 263/519
2018-05-27 19:18:16,480:INFO: Dyslipidemias Recall-at-100: 25.00%
2018-05-27 19:18:16,481:INFO: Experiment Progress: 50.0% -- 264/519
2018-05-27 19:18:43,141:INFO: Berylliosis Recall-at-100: 0.00%
2018-05-27 19:18:43,142:INFO: Experiment Progress: 51.0% -- 265/519
2018-05-27 19:19:12,006:INFO: Mental Retardation, X-Linked Recall-at-100: 5.00%
2018-05-27 19:19:12,007:INFO: Experiment Progress: 51.0% -- 266/519
2018-05-27 19:19:35,189:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-05-27 19:19:35,190:INFO: Experiment Progress: 51.0% -- 267/519
2018-05-27 19:20:04,036:INFO: Liver neoplasms Recall-at-100: 2.91%
2018-05-27 19:20:04,036:INFO: Experiment Progress: 51.0% -- 268/519
2018-05-27 19:20:32,690:INFO: Myocardial Reperfusion Injury Recall-at-100: 20.83%
2018-05-27 19:20:32,691:INFO: Experiment Progress: 51.0% -- 269/519
2018-05-27 19:21:02,448:INFO: Microsatellite Instability Recall-at-100: 5.00%
2018-05-27 19:21:02,448:INFO: Experiment Progress: 52.0% -- 270/519
2018-05-27 19:21:31,842:INFO: Night blindness, congenital stationary Recall-at-100: 25.00%
2018-05-27 19:21:31,843:INFO: Experiment Progress: 52.0% -- 271/519
2018-05-27 19:22:00,892:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-05-27 19:22:00,893:INFO: Experiment Progress: 52.0% -- 272/519
2018-05-27 19:22:30,259:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-05-27 19:22:30,260:INFO: Experiment Progress: 52.0% -- 273/519
2018-05-27 19:22:59,310:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-05-27 19:22:59,311:INFO: Experiment Progress: 52.0% -- 274/519
2018-05-27 19:23:28,884:INFO: Learning Disorders Recall-at-100: 10.00%
2018-05-27 19:23:28,885:INFO: Experiment Progress: 52.0% -- 275/519
2018-05-27 19:23:57,681:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 50.00%
2018-05-27 19:23:57,682:INFO: Experiment Progress: 53.0% -- 276/519
2018-05-27 19:24:25,911:INFO: Marfan Syndrome Recall-at-100: 50.00%
2018-05-27 19:24:25,912:INFO: Experiment Progress: 53.0% -- 277/519
2018-05-27 19:24:55,109:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 0.00%
2018-05-27 19:24:55,110:INFO: Experiment Progress: 53.0% -- 278/519
2018-05-27 19:25:24,151:INFO: Lung Neoplasms Recall-at-100: 12.16%
2018-05-27 19:25:24,152:INFO: Experiment Progress: 53.0% -- 279/519
2018-05-27 19:25:44,236:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-05-27 19:25:44,236:INFO: Experiment Progress: 53.0% -- 280/519
2018-05-27 19:26:13,038:INFO: Inflammatory Bowel Diseases Recall-at-100: 0.00%
2018-05-27 19:26:13,038:INFO: Experiment Progress: 54.0% -- 281/519
2018-05-27 19:26:42,258:INFO: Mammary Neoplasms Recall-at-100: 6.63%
2018-05-27 19:26:42,259:INFO: Experiment Progress: 54.0% -- 282/519
2018-05-27 19:26:59,909:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-05-27 19:26:59,910:INFO: Experiment Progress: 54.0% -- 283/519
2018-05-27 19:27:30,124:INFO: Neuralgia Recall-at-100: 0.00%
2018-05-27 19:27:30,125:INFO: Experiment Progress: 54.0% -- 284/519
2018-05-27 19:27:59,896:INFO: Neural Tube Defects Recall-at-100: 3.33%
2018-05-27 19:27:59,897:INFO: Experiment Progress: 54.0% -- 285/519
2018-05-27 19:28:29,301:INFO: Dermatitis, Allergic Contact Recall-at-100: 1.67%
2018-05-27 19:28:29,302:INFO: Experiment Progress: 55.0% -- 286/519
2018-05-27 19:28:58,102:INFO: Inborn Errors of Metabolism Recall-at-100: 0.00%
2018-05-27 19:28:58,103:INFO: Experiment Progress: 55.0% -- 287/519
2018-05-27 19:29:28,603:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-05-27 19:29:28,604:INFO: Experiment Progress: 55.0% -- 288/519
2018-05-27 19:29:56,420:INFO: Intestinal Neoplasms Recall-at-100: 45.00%
2018-05-27 19:29:56,421:INFO: Experiment Progress: 55.0% -- 289/519
2018-05-27 19:30:26,630:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-05-27 19:30:26,631:INFO: Experiment Progress: 55.0% -- 290/519
2018-05-27 19:30:55,564:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-05-27 19:30:55,565:INFO: Experiment Progress: 56.0% -- 291/519
2018-05-27 19:31:24,369:INFO: Age related macular degeneration Recall-at-100: 8.33%
2018-05-27 19:31:24,369:INFO: Experiment Progress: 56.0% -- 292/519
2018-05-27 19:31:53,590:INFO: Hyperplasia Recall-at-100: 6.67%
2018-05-27 19:31:53,591:INFO: Experiment Progress: 56.0% -- 293/519
2018-05-27 19:32:22,387:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-05-27 19:32:22,388:INFO: Experiment Progress: 56.0% -- 294/519
2018-05-27 19:32:51,497:INFO: Spina Bifida Recall-at-100: 10.00%
2018-05-27 19:32:51,497:INFO: Experiment Progress: 56.0% -- 295/519
2018-05-27 19:33:20,953:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 5.00%
2018-05-27 19:33:20,954:INFO: Experiment Progress: 57.0% -- 296/519
2018-05-27 19:33:50,682:INFO: Bardet-Biedl Syndrome Recall-at-100: 58.33%
2018-05-27 19:33:50,682:INFO: Experiment Progress: 57.0% -- 297/519
2018-05-27 19:34:20,274:INFO: Keloid Recall-at-100: 15.00%
2018-05-27 19:34:20,274:INFO: Experiment Progress: 57.0% -- 298/519
2018-05-27 19:34:48,636:INFO: melanoma Recall-at-100: 2.05%
2018-05-27 19:34:48,643:INFO: Experiment Progress: 57.0% -- 299/519
2018-05-27 19:35:17,524:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 5.00%
2018-05-27 19:35:17,525:INFO: Experiment Progress: 57.0% -- 300/519
2018-05-27 19:35:46,597:INFO: Pneumonia Recall-at-100: 36.00%
2018-05-27 19:35:46,599:INFO: Experiment Progress: 57.0% -- 301/519
2018-05-27 19:36:17,218:INFO: Disease Progression Recall-at-100: 4.04%
2018-05-27 19:36:17,220:INFO: Experiment Progress: 58.0% -- 302/519
2018-05-27 19:36:46,468:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-05-27 19:36:46,469:INFO: Experiment Progress: 58.0% -- 303/519
2018-05-27 19:37:16,106:INFO: Severe Combined Immunodeficiency Recall-at-100: 20.00%
2018-05-27 19:37:16,108:INFO: Experiment Progress: 58.0% -- 304/519
2018-05-27 19:37:45,810:INFO: Malignant neoplasm of ovary Recall-at-100: 5.00%
2018-05-27 19:37:45,810:INFO: Experiment Progress: 58.0% -- 305/519
2018-05-27 19:38:15,917:INFO: Pheochromocytoma Recall-at-100: 20.00%
2018-05-27 19:38:15,918:INFO: Experiment Progress: 58.0% -- 306/519
2018-05-27 19:38:45,310:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-05-27 19:38:45,311:INFO: Experiment Progress: 59.0% -- 307/519
2018-05-27 19:39:15,549:INFO: Hypogonadism Recall-at-100: 45.00%
2018-05-27 19:39:15,550:INFO: Experiment Progress: 59.0% -- 308/519
2018-05-27 19:39:44,916:INFO: Movement Disorders Recall-at-100: 23.33%
2018-05-27 19:39:44,917:INFO: Experiment Progress: 59.0% -- 309/519
2018-05-27 19:40:14,158:INFO: Sarcoma Recall-at-100: 0.00%
2018-05-27 19:40:14,160:INFO: Experiment Progress: 59.0% -- 310/519
2018-05-27 19:40:43,813:INFO: Lymphatic Metastasis Recall-at-100: 5.00%
2018-05-27 19:40:43,815:INFO: Experiment Progress: 59.0% -- 311/519
2018-05-27 19:41:13,147:INFO: Hypoglycemia Recall-at-100: 10.00%
2018-05-27 19:41:13,148:INFO: Experiment Progress: 60.0% -- 312/519
2018-05-27 19:41:42,513:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-05-27 19:41:42,513:INFO: Experiment Progress: 60.0% -- 313/519
2018-05-27 19:42:12,053:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-05-27 19:42:12,053:INFO: Experiment Progress: 60.0% -- 314/519
2018-05-27 19:42:41,867:INFO: Colorectal Cancer Recall-at-100: 6.67%
2018-05-27 19:42:41,868:INFO: Experiment Progress: 60.0% -- 315/519
2018-05-27 19:43:10,651:INFO: Atherosclerosis Recall-at-100: 13.33%
2018-05-27 19:43:10,652:INFO: Experiment Progress: 60.0% -- 316/519
2018-05-27 19:43:40,423:INFO: Asthma Recall-at-100: 1.91%
2018-05-27 19:43:40,424:INFO: Experiment Progress: 61.0% -- 317/519
2018-05-27 19:44:09,812:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 28.33%
2018-05-27 19:44:09,813:INFO: Experiment Progress: 61.0% -- 318/519
2018-05-27 19:44:40,115:INFO: Skin Neoplasms Recall-at-100: 12.00%
2018-05-27 19:44:40,117:INFO: Experiment Progress: 61.0% -- 319/519
2018-05-27 19:45:08,447:INFO: Seizures Recall-at-100: 3.22%
2018-05-27 19:45:08,448:INFO: Experiment Progress: 61.0% -- 320/519
2018-05-27 19:45:38,032:INFO: Alzheimer's Disease Recall-at-100: 4.81%
2018-05-27 19:45:38,033:INFO: Experiment Progress: 61.0% -- 321/519
2018-05-27 19:46:06,580:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-05-27 19:46:06,581:INFO: Experiment Progress: 62.0% -- 322/519
2018-05-27 19:46:35,686:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 28.50%
2018-05-27 19:46:35,687:INFO: Experiment Progress: 62.0% -- 323/519
2018-05-27 19:47:04,550:INFO: Gastrointestinal Diseases Recall-at-100: 10.00%
2018-05-27 19:47:04,551:INFO: Experiment Progress: 62.0% -- 324/519
2018-05-27 19:47:34,347:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 25.00%
2018-05-27 19:47:34,348:INFO: Experiment Progress: 62.0% -- 325/519
2018-05-27 19:48:04,154:INFO: Retinal Degeneration Recall-at-100: 0.00%
2018-05-27 19:48:04,155:INFO: Experiment Progress: 62.0% -- 326/519
2018-05-27 19:48:32,837:INFO: Retinal Diseases Recall-at-100: 3.33%
2018-05-27 19:48:32,838:INFO: Experiment Progress: 63.0% -- 327/519
2018-05-27 19:49:02,464:INFO: Methylmalonic acidemia Recall-at-100: 40.00%
2018-05-27 19:49:02,465:INFO: Experiment Progress: 63.0% -- 328/519
2018-05-27 19:49:31,469:INFO: Contact Dermatitis Recall-at-100: 8.57%
2018-05-27 19:49:31,471:INFO: Experiment Progress: 63.0% -- 329/519
2018-05-27 19:50:00,196:INFO: Dermatitis, Atopic Recall-at-100: 27.50%
2018-05-27 19:50:00,197:INFO: Experiment Progress: 63.0% -- 330/519
2018-05-27 19:50:29,195:INFO: Coronary heart disease Recall-at-100: 8.33%
2018-05-27 19:50:29,196:INFO: Experiment Progress: 63.0% -- 331/519
2018-05-27 19:50:58,873:INFO: Osteoporosis Recall-at-100: 6.67%
2018-05-27 19:50:58,875:INFO: Experiment Progress: 63.0% -- 332/519
2018-05-27 19:51:29,361:INFO: Cardiomegaly Recall-at-100: 7.86%
2018-05-27 19:51:29,362:INFO: Experiment Progress: 64.0% -- 333/519
2018-05-27 19:51:59,186:INFO: Heart failure Recall-at-100: 15.00%
2018-05-27 19:51:59,187:INFO: Experiment Progress: 64.0% -- 334/519
2018-05-27 19:52:28,620:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 60.00%
2018-05-27 19:52:28,621:INFO: Experiment Progress: 64.0% -- 335/519
2018-05-27 19:52:57,802:INFO: Major Depressive Disorder Recall-at-100: 6.67%
2018-05-27 19:52:57,804:INFO: Experiment Progress: 64.0% -- 336/519
2018-05-27 19:53:27,593:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-05-27 19:53:27,594:INFO: Experiment Progress: 64.0% -- 337/519
2018-05-27 19:53:56,684:INFO: Inflammation Recall-at-100: 12.00%
2018-05-27 19:53:56,685:INFO: Experiment Progress: 65.0% -- 338/519
2018-05-27 19:54:25,891:INFO: Diabetic Neuropathies Recall-at-100: 15.00%
2018-05-27 19:54:25,892:INFO: Experiment Progress: 65.0% -- 339/519
2018-05-27 19:54:55,196:INFO: Male infertility Recall-at-100: 5.00%
2018-05-27 19:54:55,196:INFO: Experiment Progress: 65.0% -- 340/519
2018-05-27 19:55:24,709:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-05-27 19:55:24,710:INFO: Experiment Progress: 65.0% -- 341/519
2018-05-27 19:55:54,425:INFO: Female infertility Recall-at-100: 35.00%
2018-05-27 19:55:54,426:INFO: Experiment Progress: 65.0% -- 342/519
2018-05-27 19:56:22,465:INFO: leukemia Recall-at-100: 21.67%
2018-05-27 19:56:22,465:INFO: Experiment Progress: 66.0% -- 343/519
2018-05-27 19:56:51,945:INFO: Ulcerative Colitis Recall-at-100: 7.50%
2018-05-27 19:56:51,946:INFO: Experiment Progress: 66.0% -- 344/519
2018-05-27 19:57:20,777:INFO: Influenza Recall-at-100: 18.00%
2018-05-27 19:57:20,778:INFO: Experiment Progress: 66.0% -- 345/519
2018-05-27 19:57:49,500:INFO: Nephritis, Interstitial Recall-at-100: 40.00%
2018-05-27 19:57:49,501:INFO: Experiment Progress: 66.0% -- 346/519
2018-05-27 19:58:18,598:INFO: Sjogren's Syndrome Recall-at-100: 0.00%
2018-05-27 19:58:18,598:INFO: Experiment Progress: 66.0% -- 347/519
2018-05-27 19:58:48,258:INFO: Infant length Recall-at-100: 0.00%
2018-05-27 19:58:48,258:INFO: Experiment Progress: 67.0% -- 348/519
2018-05-27 19:59:18,415:INFO: Child Development Disorders, Pervasive Recall-at-100: 9.67%
2018-05-27 19:59:18,415:INFO: Experiment Progress: 67.0% -- 349/519
2018-05-27 19:59:46,936:INFO: Substance Withdrawal Syndrome Recall-at-100: 21.00%
2018-05-27 19:59:46,937:INFO: Experiment Progress: 67.0% -- 350/519
2018-05-27 20:00:15,553:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-05-27 20:00:15,554:INFO: Experiment Progress: 67.0% -- 351/519
2018-05-27 20:00:44,178:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 3.33%
2018-05-27 20:00:44,179:INFO: Experiment Progress: 67.0% -- 352/519
2018-05-27 20:01:13,165:INFO: Developmental Disabilities Recall-at-100: 0.00%
2018-05-27 20:01:13,166:INFO: Experiment Progress: 68.0% -- 353/519
2018-05-27 20:01:42,846:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-05-27 20:01:42,847:INFO: Experiment Progress: 68.0% -- 354/519
2018-05-27 20:02:11,922:INFO: Cholestasis Recall-at-100: 15.00%
2018-05-27 20:02:11,922:INFO: Experiment Progress: 68.0% -- 355/519
2018-05-27 20:02:41,619:INFO: Pulmonary Hypertension Recall-at-100: 3.33%
2018-05-27 20:02:41,620:INFO: Experiment Progress: 68.0% -- 356/519
2018-05-27 20:03:11,604:INFO: Papillary thyroid carcinoma Recall-at-100: 6.67%
2018-05-27 20:03:11,605:INFO: Experiment Progress: 68.0% -- 357/519
2018-05-27 20:03:40,703:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-05-27 20:03:40,703:INFO: Experiment Progress: 68.0% -- 358/519
2018-05-27 20:04:10,206:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 5.00%
2018-05-27 20:04:10,207:INFO: Experiment Progress: 69.0% -- 359/519
2018-05-27 20:04:38,862:INFO: Hay fever Recall-at-100: 0.00%
2018-05-27 20:04:38,863:INFO: Experiment Progress: 69.0% -- 360/519
2018-05-27 20:05:08,376:INFO: Hypercholesterolemia, Familial Recall-at-100: 55.00%
2018-05-27 20:05:08,377:INFO: Experiment Progress: 69.0% -- 361/519
2018-05-27 20:05:37,572:INFO: Down Syndrome Recall-at-100: 2.22%
2018-05-27 20:05:37,573:INFO: Experiment Progress: 69.0% -- 362/519
2018-05-27 20:06:06,396:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 30.00%
2018-05-27 20:06:06,397:INFO: Experiment Progress: 69.0% -- 363/519
2018-05-27 20:06:35,293:INFO: Semilobar Holoprosencephaly Recall-at-100: 0.00%
2018-05-27 20:06:35,294:INFO: Experiment Progress: 70.0% -- 364/519
2018-05-27 20:07:04,904:INFO: Hypertriglyceridemia Recall-at-100: 20.00%
2018-05-27 20:07:04,905:INFO: Experiment Progress: 70.0% -- 365/519
2018-05-27 20:07:31,001:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 0.00%
2018-05-27 20:07:31,003:INFO: Experiment Progress: 70.0% -- 366/519
2018-05-27 20:08:00,608:INFO: Metabolic Syndrome X Recall-at-100: 4.50%
2018-05-27 20:08:00,609:INFO: Experiment Progress: 70.0% -- 367/519
2018-05-27 20:08:29,119:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-05-27 20:08:29,120:INFO: Experiment Progress: 70.0% -- 368/519
2018-05-27 20:08:57,986:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 5.30%
2018-05-27 20:08:57,987:INFO: Experiment Progress: 71.0% -- 369/519
2018-05-27 20:09:27,351:INFO: Malignant neoplasm of prostate Recall-at-100: 0.00%
2018-05-27 20:09:27,352:INFO: Experiment Progress: 71.0% -- 370/519
2018-05-27 20:09:57,046:INFO: Renal Insufficiency Recall-at-100: 40.00%
2018-05-27 20:09:57,047:INFO: Experiment Progress: 71.0% -- 371/519
2018-05-27 20:10:23,467:INFO: Jeune thoracic dystrophy Recall-at-100: 22.22%
2018-05-27 20:10:23,467:INFO: Experiment Progress: 71.0% -- 372/519
2018-05-27 20:10:52,587:INFO: Renal Cell Carcinoma Recall-at-100: 3.27%
2018-05-27 20:10:52,588:INFO: Experiment Progress: 71.0% -- 373/519
2018-05-27 20:11:22,514:INFO: Squamous cell carcinoma Recall-at-100: 13.19%
2018-05-27 20:11:22,515:INFO: Experiment Progress: 72.0% -- 374/519
2018-05-27 20:11:51,129:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 8.94%
2018-05-27 20:11:51,129:INFO: Experiment Progress: 72.0% -- 375/519
2018-05-27 20:12:20,286:INFO: Manganese Poisoning Recall-at-100: 20.00%
2018-05-27 20:12:20,287:INFO: Experiment Progress: 72.0% -- 376/519
2018-05-27 20:12:49,099:INFO: Ventricular Dysfunction, Left Recall-at-100: 5.00%
2018-05-27 20:12:49,100:INFO: Experiment Progress: 72.0% -- 377/519
2018-05-27 20:13:19,211:INFO: Carcinoma, Transitional Cell Recall-at-100: 18.33%
2018-05-27 20:13:19,212:INFO: Experiment Progress: 72.0% -- 378/519
2018-05-27 20:13:47,932:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-05-27 20:13:47,933:INFO: Experiment Progress: 73.0% -- 379/519
2018-05-27 20:14:16,478:INFO: Tobacco Use Disorder Recall-at-100: 0.00%
2018-05-27 20:14:16,478:INFO: Experiment Progress: 73.0% -- 380/519
2018-05-27 20:14:46,066:INFO: Proteinuria Recall-at-100: 2.50%
2018-05-27 20:14:46,067:INFO: Experiment Progress: 73.0% -- 381/519
2018-05-27 20:15:15,442:INFO: Diabetic Nephropathy Recall-at-100: 8.33%
2018-05-27 20:15:15,443:INFO: Experiment Progress: 73.0% -- 382/519
2018-05-27 20:15:44,337:INFO: Williams Syndrome Recall-at-100: 0.00%
2018-05-27 20:15:44,338:INFO: Experiment Progress: 73.0% -- 383/519
2018-05-27 20:16:14,310:INFO: Oral Submucous Fibrosis Recall-at-100: 50.00%
2018-05-27 20:16:14,311:INFO: Experiment Progress: 73.0% -- 384/519
2018-05-27 20:16:42,328:INFO: Adenoma Recall-at-100: 5.83%
2018-05-27 20:16:42,329:INFO: Experiment Progress: 74.0% -- 385/519
2018-05-27 20:17:11,015:INFO: Neutropenia Recall-at-100: 0.00%
2018-05-27 20:17:11,017:INFO: Experiment Progress: 74.0% -- 386/519
2018-05-27 20:17:40,439:INFO: Poor school performance Recall-at-100: 0.00%
2018-05-27 20:17:40,440:INFO: Experiment Progress: 74.0% -- 387/519
2018-05-27 20:18:08,654:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-05-27 20:18:08,654:INFO: Experiment Progress: 74.0% -- 388/519
2018-05-27 20:18:37,903:INFO: Cardiovascular Diseases Recall-at-100: 14.00%
2018-05-27 20:18:37,904:INFO: Experiment Progress: 74.0% -- 389/519
2018-05-27 20:19:06,682:INFO: Fibrinogen Adverse Event Recall-at-100: 15.00%
2018-05-27 20:19:06,682:INFO: Experiment Progress: 75.0% -- 390/519
2018-05-27 20:19:35,700:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 3.79%
2018-05-27 20:19:35,701:INFO: Experiment Progress: 75.0% -- 391/519
2018-05-27 20:20:04,821:INFO: Thrombocytopenia Recall-at-100: 15.00%
2018-05-27 20:20:04,822:INFO: Experiment Progress: 75.0% -- 392/519
2018-05-27 20:20:34,144:INFO: Sezary Syndrome Recall-at-100: 20.00%
2018-05-27 20:20:34,145:INFO: Experiment Progress: 75.0% -- 393/519
2018-05-27 20:21:02,565:INFO: Nuclear non-senile cataract Recall-at-100: 40.00%
2018-05-27 20:21:02,566:INFO: Experiment Progress: 75.0% -- 394/519
2018-05-27 20:21:31,163:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-05-27 20:21:31,164:INFO: Experiment Progress: 76.0% -- 395/519
2018-05-27 20:22:00,501:INFO: hearing impairment Recall-at-100: 0.00%
2018-05-27 20:22:00,502:INFO: Experiment Progress: 76.0% -- 396/519
2018-05-27 20:22:29,264:INFO: Psychotic Disorders Recall-at-100: 15.00%
2018-05-27 20:22:29,265:INFO: Experiment Progress: 76.0% -- 397/519
2018-05-27 20:22:58,967:INFO: Anxiety Disorders Recall-at-100: 5.00%
2018-05-27 20:22:58,968:INFO: Experiment Progress: 76.0% -- 398/519
2018-05-27 20:23:27,897:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 0.00%
2018-05-27 20:23:27,898:INFO: Experiment Progress: 76.0% -- 399/519
2018-05-27 20:23:58,260:INFO: Motion Sickness Recall-at-100: 0.00%
2018-05-27 20:23:58,261:INFO: Experiment Progress: 77.0% -- 400/519
2018-05-27 20:24:27,104:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 23.33%
2018-05-27 20:24:27,105:INFO: Experiment Progress: 77.0% -- 401/519
2018-05-27 20:24:56,308:INFO: Lymphoma, Follicular Recall-at-100: 0.00%
2018-05-27 20:24:56,309:INFO: Experiment Progress: 77.0% -- 402/519
2018-05-27 20:25:25,261:INFO: Thrombocythemia, Essential Recall-at-100: 15.00%
2018-05-27 20:25:25,261:INFO: Experiment Progress: 77.0% -- 403/519
2018-05-27 20:25:51,368:INFO: Arthritis Recall-at-100: 0.00%
2018-05-27 20:25:51,369:INFO: Experiment Progress: 77.0% -- 404/519
2018-05-27 20:26:19,946:INFO: Hypotension Recall-at-100: 9.33%
2018-05-27 20:26:19,947:INFO: Experiment Progress: 78.0% -- 405/519
2018-05-27 20:26:49,301:INFO: Reperfusion Injury Recall-at-100: 16.39%
2018-05-27 20:26:49,301:INFO: Experiment Progress: 78.0% -- 406/519
2018-05-27 20:27:18,558:INFO: Heat Stroke Recall-at-100: 80.00%
2018-05-27 20:27:18,558:INFO: Experiment Progress: 78.0% -- 407/519
2018-05-27 20:27:47,263:INFO: Hemangiosarcoma Recall-at-100: 30.00%
2018-05-27 20:27:47,263:INFO: Experiment Progress: 78.0% -- 408/519
2018-05-27 20:28:15,876:INFO: Drug Allergy Recall-at-100: 12.50%
2018-05-27 20:28:15,876:INFO: Experiment Progress: 78.0% -- 409/519
2018-05-27 20:28:45,078:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 10.00%
2018-05-27 20:28:45,079:INFO: Experiment Progress: 78.0% -- 410/519
2018-05-27 20:29:14,287:INFO: Medulloblastoma Recall-at-100: 4.50%
2018-05-27 20:29:14,288:INFO: Experiment Progress: 79.0% -- 411/519
2018-05-27 20:29:43,378:INFO: Cleft Lip Recall-at-100: 38.33%
2018-05-27 20:29:43,379:INFO: Experiment Progress: 79.0% -- 412/519
2018-05-27 20:30:12,824:INFO: Cleft Palate Recall-at-100: 30.00%
2018-05-27 20:30:12,825:INFO: Experiment Progress: 79.0% -- 413/519
2018-05-27 20:30:40,995:INFO: Muscle Weakness Recall-at-100: 2.22%
2018-05-27 20:30:40,996:INFO: Experiment Progress: 79.0% -- 414/519
2018-05-27 20:31:11,161:INFO: Mental disorders Recall-at-100: 35.00%
2018-05-27 20:31:11,162:INFO: Experiment Progress: 79.0% -- 415/519
2018-05-27 20:31:40,237:INFO: Astrocytoma Recall-at-100: 35.00%
2018-05-27 20:31:40,238:INFO: Experiment Progress: 80.0% -- 416/519
2018-05-27 20:32:10,005:INFO: Anemia, Diamond-Blackfan Recall-at-100: 80.00%
2018-05-27 20:32:10,006:INFO: Experiment Progress: 80.0% -- 417/519
2018-05-27 20:32:39,082:INFO: Asthma, Aspirin-Induced Recall-at-100: 15.00%
2018-05-27 20:32:39,083:INFO: Experiment Progress: 80.0% -- 418/519
2018-05-27 20:33:08,635:INFO: Leber Congenital Amaurosis Recall-at-100: 13.33%
2018-05-27 20:33:08,637:INFO: Experiment Progress: 80.0% -- 419/519
2018-05-27 20:33:37,464:INFO: Cachexia Recall-at-100: 20.00%
2018-05-27 20:33:37,465:INFO: Experiment Progress: 80.0% -- 420/519
2018-05-27 20:34:06,527:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-05-27 20:34:06,528:INFO: Experiment Progress: 81.0% -- 421/519
2018-05-27 20:34:35,968:INFO: Respiratory Hypersensitivity Recall-at-100: 0.00%
2018-05-27 20:34:35,969:INFO: Experiment Progress: 81.0% -- 422/519
2018-05-27 20:35:05,339:INFO: Nasopharyngeal carcinoma Recall-at-100: 10.00%
2018-05-27 20:35:05,341:INFO: Experiment Progress: 81.0% -- 423/519
2018-05-27 20:35:34,254:INFO: Hyperalgesia Recall-at-100: 15.95%
2018-05-27 20:35:34,254:INFO: Experiment Progress: 81.0% -- 424/519
2018-05-27 20:36:03,436:INFO: Meningioma Recall-at-100: 10.00%
2018-05-27 20:36:03,437:INFO: Experiment Progress: 81.0% -- 425/519
2018-05-27 20:36:33,659:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-05-27 20:36:33,661:INFO: Experiment Progress: 82.0% -- 426/519
2018-05-27 20:37:03,067:INFO: Intellectual Disability Recall-at-100: 0.00%
2018-05-27 20:37:03,068:INFO: Experiment Progress: 82.0% -- 427/519
2018-05-27 20:37:31,998:INFO: Graves Disease Recall-at-100: 5.00%
2018-05-27 20:37:32,000:INFO: Experiment Progress: 82.0% -- 428/519
2018-05-27 20:38:00,826:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-05-27 20:38:00,827:INFO: Experiment Progress: 82.0% -- 429/519
2018-05-27 20:38:30,044:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 70.00%
2018-05-27 20:38:30,045:INFO: Experiment Progress: 82.0% -- 430/519
2018-05-27 20:38:59,512:INFO: Atrial Fibrillation Recall-at-100: 11.67%
2018-05-27 20:38:59,513:INFO: Experiment Progress: 83.0% -- 431/519
2018-05-27 20:39:28,350:INFO: Hepatitis, Chronic Recall-at-100: 20.00%
2018-05-27 20:39:28,351:INFO: Experiment Progress: 83.0% -- 432/519
2018-05-27 20:39:58,093:INFO: Behcet Syndrome Recall-at-100: 5.00%
2018-05-27 20:39:58,094:INFO: Experiment Progress: 83.0% -- 433/519
2018-05-27 20:40:27,655:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 5.71%
2018-05-27 20:40:27,656:INFO: Experiment Progress: 83.0% -- 434/519
2018-05-27 20:40:56,256:INFO: Diabetes Mellitus, Experimental Recall-at-100: 2.73%
2018-05-27 20:40:56,257:INFO: Experiment Progress: 83.0% -- 435/519
2018-05-27 20:41:25,553:INFO: Parkinsonian Disorders Recall-at-100: 35.00%
2018-05-27 20:41:25,553:INFO: Experiment Progress: 84.0% -- 436/519
2018-05-27 20:41:54,347:INFO: Necrosis Recall-at-100: 8.00%
2018-05-27 20:41:54,348:INFO: Experiment Progress: 84.0% -- 437/519
2018-05-27 20:42:23,253:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-05-27 20:42:23,260:INFO: Experiment Progress: 84.0% -- 438/519
2018-05-27 20:42:52,577:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-05-27 20:42:52,578:INFO: Experiment Progress: 84.0% -- 439/519
2018-05-27 20:43:21,586:INFO: Hypersensitivity Recall-at-100: 17.62%
2018-05-27 20:43:21,586:INFO: Experiment Progress: 84.0% -- 440/519
2018-05-27 20:43:50,048:INFO: Myopia Recall-at-100: 0.00%
2018-05-27 20:43:50,048:INFO: Experiment Progress: 84.0% -- 441/519
2018-05-27 20:44:18,355:INFO: Hyperemia Recall-at-100: 10.00%
2018-05-27 20:44:18,355:INFO: Experiment Progress: 85.0% -- 442/519
2018-05-27 20:44:47,995:INFO: Tooth Abnormalities Recall-at-100: 30.00%
2018-05-27 20:44:47,996:INFO: Experiment Progress: 85.0% -- 443/519
2018-05-27 20:45:18,412:INFO: Hyperglycemia Recall-at-100: 5.00%
2018-05-27 20:45:18,413:INFO: Experiment Progress: 85.0% -- 444/519
2018-05-27 20:45:47,829:INFO: Noonan Syndrome Recall-at-100: 65.00%
2018-05-27 20:45:47,830:INFO: Experiment Progress: 85.0% -- 445/519
2018-05-27 20:46:16,712:INFO: Hyperinsulinism Recall-at-100: 25.00%
2018-05-27 20:46:16,713:INFO: Experiment Progress: 85.0% -- 446/519
2018-05-27 20:46:45,745:INFO: Edema Recall-at-100: 15.00%
2018-05-27 20:46:45,746:INFO: Experiment Progress: 86.0% -- 447/519
2018-05-27 20:47:14,427:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-05-27 20:47:14,428:INFO: Experiment Progress: 86.0% -- 448/519
2018-05-27 20:47:43,354:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-05-27 20:47:43,355:INFO: Experiment Progress: 86.0% -- 449/519
2018-05-27 20:48:12,261:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-05-27 20:48:12,262:INFO: Experiment Progress: 86.0% -- 450/519
2018-05-27 20:48:41,917:INFO: Tachycardia, Ventricular Recall-at-100: 20.00%
2018-05-27 20:48:41,917:INFO: Experiment Progress: 86.0% -- 451/519
2018-05-27 20:49:10,924:INFO: Dystonia Recall-at-100: 0.00%
2018-05-27 20:49:10,925:INFO: Experiment Progress: 87.0% -- 452/519
2018-05-27 20:49:38,931:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 5.00%
2018-05-27 20:49:38,932:INFO: Experiment Progress: 87.0% -- 453/519
2018-05-27 20:50:08,417:INFO: Pulmonary Embolism Recall-at-100: 30.00%
2018-05-27 20:50:08,419:INFO: Experiment Progress: 87.0% -- 454/519
2018-05-27 20:50:38,243:INFO: Pulmonary Fibrosis Recall-at-100: 37.00%
2018-05-27 20:50:38,244:INFO: Experiment Progress: 87.0% -- 455/519
2018-05-27 20:51:07,569:INFO: West Syndrome Recall-at-100: 10.00%
2018-05-27 20:51:07,570:INFO: Experiment Progress: 87.0% -- 456/519
2018-05-27 20:51:37,502:INFO: Cerebral Hemorrhage Recall-at-100: 53.33%
2018-05-27 20:51:37,502:INFO: Experiment Progress: 88.0% -- 457/519
2018-05-27 20:52:08,191:INFO: Romano-Ward Syndrome Recall-at-100: 40.00%
2018-05-27 20:52:08,191:INFO: Experiment Progress: 88.0% -- 458/519
2018-05-27 20:52:37,360:INFO: Mouth Neoplasms Recall-at-100: 12.50%
2018-05-27 20:52:37,361:INFO: Experiment Progress: 88.0% -- 459/519
2018-05-27 20:53:07,257:INFO: Liver Cirrhosis Recall-at-100: 29.00%
2018-05-27 20:53:07,258:INFO: Experiment Progress: 88.0% -- 460/519
2018-05-27 20:53:37,248:INFO: Neoplasm Recurrence, Local Recall-at-100: 11.67%
2018-05-27 20:53:37,249:INFO: Experiment Progress: 88.0% -- 461/519
2018-05-27 20:54:06,576:INFO: Obesity Recall-at-100: 3.51%
2018-05-27 20:54:06,577:INFO: Experiment Progress: 89.0% -- 462/519
2018-05-27 20:54:36,490:INFO: Biliary cirrhosis Recall-at-100: 11.67%
2018-05-27 20:54:36,492:INFO: Experiment Progress: 89.0% -- 463/519
2018-05-27 20:55:05,893:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 11.50%
2018-05-27 20:55:05,894:INFO: Experiment Progress: 89.0% -- 464/519
2018-05-27 20:55:34,904:INFO: Cardiomyopathies Recall-at-100: 8.89%
2018-05-27 20:55:34,906:INFO: Experiment Progress: 89.0% -- 465/519
2018-05-27 20:56:04,954:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-05-27 20:56:04,955:INFO: Experiment Progress: 89.0% -- 466/519
2018-05-27 20:56:34,244:INFO: Dyskeratosis Congenita Recall-at-100: 45.00%
2018-05-27 20:56:34,245:INFO: Experiment Progress: 89.0% -- 467/519
2018-05-27 20:57:04,196:INFO: Uremia Recall-at-100: 20.00%
2018-05-27 20:57:04,198:INFO: Experiment Progress: 90.0% -- 468/519
2018-05-27 20:57:33,134:INFO: Depressive disorder Recall-at-100: 3.33%
2018-05-27 20:57:33,135:INFO: Experiment Progress: 90.0% -- 469/519
2018-05-27 20:58:02,854:INFO: Thrombosis Recall-at-100: 32.50%
2018-05-27 20:58:02,854:INFO: Experiment Progress: 90.0% -- 470/519
2018-05-27 20:58:32,431:INFO: nervous system disorder Recall-at-100: 4.00%
2018-05-27 20:58:32,432:INFO: Experiment Progress: 90.0% -- 471/519
2018-05-27 20:59:01,416:INFO: Lymphoma Recall-at-100: 0.00%
2018-05-27 20:59:01,417:INFO: Experiment Progress: 90.0% -- 472/519
2018-05-27 20:59:30,343:INFO: IGA Glomerulonephritis Recall-at-100: 3.26%
2018-05-27 20:59:30,344:INFO: Experiment Progress: 91.0% -- 473/519
2018-05-27 20:59:59,143:INFO: Kidney Neoplasm Recall-at-100: 10.00%
2018-05-27 20:59:59,144:INFO: Experiment Progress: 91.0% -- 474/519
2018-05-27 21:00:28,793:INFO: Hypothermia, natural Recall-at-100: 0.00%
2018-05-27 21:00:28,794:INFO: Experiment Progress: 91.0% -- 475/519
2018-05-27 21:00:58,917:INFO: Focal glomerulosclerosis Recall-at-100: 10.00%
2018-05-27 21:00:58,918:INFO: Experiment Progress: 91.0% -- 476/519
2018-05-27 21:01:28,156:INFO: Hepatitis B, Chronic Recall-at-100: 10.00%
2018-05-27 21:01:28,157:INFO: Experiment Progress: 91.0% -- 477/519
2018-05-27 21:01:57,613:INFO: Drug Eruptions Recall-at-100: 5.00%
2018-05-27 21:01:57,614:INFO: Experiment Progress: 92.0% -- 478/519
2018-05-27 21:02:27,200:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-05-27 21:02:27,201:INFO: Experiment Progress: 92.0% -- 479/519
2018-05-27 21:02:56,604:INFO: Stomach Neoplasms Recall-at-100: 2.45%
2018-05-27 21:02:56,605:INFO: Experiment Progress: 92.0% -- 480/519
2018-05-27 21:03:26,969:INFO: Osteosarcoma Recall-at-100: 11.67%
2018-05-27 21:03:26,970:INFO: Experiment Progress: 92.0% -- 481/519
2018-05-27 21:03:55,978:INFO: Vitiligo Recall-at-100: 10.00%
2018-05-27 21:03:55,978:INFO: Experiment Progress: 92.0% -- 482/519
2018-05-27 21:04:24,617:INFO: Gastric ulcer Recall-at-100: 0.00%
2018-05-27 21:04:24,619:INFO: Experiment Progress: 93.0% -- 483/519
2018-05-27 21:04:53,714:INFO: Malignant neoplasm of breast Recall-at-100: 7.86%
2018-05-27 21:04:53,715:INFO: Experiment Progress: 93.0% -- 484/519
2018-05-27 21:05:23,124:INFO: Drug-Induced Liver Injury Recall-at-100: 10.91%
2018-05-27 21:05:23,125:INFO: Experiment Progress: 93.0% -- 485/519
2018-05-27 21:05:52,726:INFO: Colitis Recall-at-100: 3.33%
2018-05-27 21:05:52,727:INFO: Experiment Progress: 93.0% -- 486/519
2018-05-27 21:06:21,431:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-05-27 21:06:21,432:INFO: Experiment Progress: 93.0% -- 487/519
2018-05-27 21:06:50,094:INFO: T-Cell Lymphoma Recall-at-100: 30.00%
2018-05-27 21:06:50,095:INFO: Experiment Progress: 94.0% -- 488/519
2018-05-27 21:07:19,299:INFO: Hyperactive behavior Recall-at-100: 23.33%
2018-05-27 21:07:19,300:INFO: Experiment Progress: 94.0% -- 489/519
2018-05-27 21:07:48,442:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-05-27 21:07:48,443:INFO: Experiment Progress: 94.0% -- 490/519
2018-05-27 21:08:17,579:INFO: Epithelial ovarian cancer Recall-at-100: 0.00%
2018-05-27 21:08:17,581:INFO: Experiment Progress: 94.0% -- 491/519
2018-05-27 21:08:45,552:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-05-27 21:08:45,553:INFO: Experiment Progress: 94.0% -- 492/519
2018-05-27 21:09:15,922:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-05-27 21:09:15,922:INFO: Experiment Progress: 94.0% -- 493/519
2018-05-27 21:09:44,829:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-05-27 21:09:44,831:INFO: Experiment Progress: 95.0% -- 494/519
2018-05-27 21:10:13,718:INFO: Female Urogenital Diseases Recall-at-100: 0.00%
2018-05-27 21:10:13,720:INFO: Experiment Progress: 95.0% -- 495/519
2018-05-27 21:10:43,246:INFO: ovarian neoplasm Recall-at-100: 8.22%
2018-05-27 21:10:43,247:INFO: Experiment Progress: 95.0% -- 496/519
2018-05-27 21:11:12,560:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 15.00%
2018-05-27 21:11:12,560:INFO: Experiment Progress: 95.0% -- 497/519
2018-05-27 21:11:42,306:INFO: Venous Thrombosis Recall-at-100: 65.00%
2018-05-27 21:11:42,306:INFO: Experiment Progress: 95.0% -- 498/519
2018-05-27 21:12:11,751:INFO: Amnesia Recall-at-100: 10.00%
2018-05-27 21:12:11,752:INFO: Experiment Progress: 96.0% -- 499/519
2018-05-27 21:12:40,181:INFO: Bladder Neoplasm Recall-at-100: 4.91%
2018-05-27 21:12:40,181:INFO: Experiment Progress: 96.0% -- 500/519
2018-05-27 21:13:10,124:INFO: Hemorrhage Recall-at-100: 15.00%
2018-05-27 21:13:10,126:INFO: Experiment Progress: 96.0% -- 501/519
2018-05-27 21:13:39,634:INFO: Status Epilepticus Recall-at-100: 11.90%
2018-05-27 21:13:39,635:INFO: Experiment Progress: 96.0% -- 502/519
2018-05-27 21:14:08,978:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-05-27 21:14:08,979:INFO: Experiment Progress: 96.0% -- 503/519
2018-05-27 21:14:39,627:INFO: Myeloid Leukemia, Chronic Recall-at-100: 21.67%
2018-05-27 21:14:39,628:INFO: Experiment Progress: 97.0% -- 504/519
2018-05-27 21:15:08,831:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-05-27 21:15:08,833:INFO: Experiment Progress: 97.0% -- 505/519
2018-05-27 21:15:37,160:INFO: Calcinosis Recall-at-100: 19.17%
2018-05-27 21:15:37,161:INFO: Experiment Progress: 97.0% -- 506/519
2018-05-27 21:16:06,910:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-05-27 21:16:06,911:INFO: Experiment Progress: 97.0% -- 507/519
2018-05-27 21:16:34,520:INFO: Left ventricular noncompaction Recall-at-100: 0.00%
2018-05-27 21:16:34,521:INFO: Experiment Progress: 97.0% -- 508/519
2018-05-27 21:17:04,271:INFO: Parkinson Disease Recall-at-100: 3.22%
2018-05-27 21:17:04,273:INFO: Experiment Progress: 98.0% -- 509/519
2018-05-27 21:17:34,152:INFO: Endometrial Neoplasms Recall-at-100: 6.00%
2018-05-27 21:17:34,153:INFO: Experiment Progress: 98.0% -- 510/519
2018-05-27 21:18:03,023:INFO: Sepsis Recall-at-100: 15.00%
2018-05-27 21:18:03,024:INFO: Experiment Progress: 98.0% -- 511/519
2018-05-27 21:18:32,258:INFO: Endometriosis Recall-at-100: 11.75%
2018-05-27 21:18:32,259:INFO: Experiment Progress: 98.0% -- 512/519
2018-05-27 21:19:01,479:INFO: Esophageal Neoplasms Recall-at-100: 11.90%
2018-05-27 21:19:01,480:INFO: Experiment Progress: 98.0% -- 513/519
2018-05-27 21:19:31,526:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-05-27 21:19:31,526:INFO: Experiment Progress: 99.0% -- 514/519
2018-05-27 21:20:01,209:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 15.00%
2018-05-27 21:20:01,210:INFO: Experiment Progress: 99.0% -- 515/519
2018-05-27 21:20:30,393:INFO: Lewy Body Disease Recall-at-100: 25.00%
2018-05-27 21:20:30,394:INFO: Experiment Progress: 99.0% -- 516/519
2018-05-27 21:20:59,385:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 10.00%
2018-05-27 21:20:59,386:INFO: Experiment Progress: 99.0% -- 517/519
2018-05-27 21:21:28,764:INFO: Neoplastic Cell Transformation Recall-at-100: 12.08%
2018-05-27 21:21:28,765:INFO: Experiment Progress: 99.0% -- 518/519
2018-05-27 21:21:58,096:INFO: Arsenic Poisoning Recall-at-100: 0.00%
